Curable composition
A curable composition with a fluoropolyether group-containing compound and (meth)acrylic monomer enhances adhesiveness, addressing the limitations of existing compositions and improving bonding capabilities.
Patent Information
- Application Number
- JP2023074581
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-04-28
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2043-04-28
AI Technical Summary
Existing curable compositions do not provide sufficient adhesiveness, limiting their effectiveness in applications requiring strong bonding.
A curable composition comprising a fluoropolyether group-containing compound, (meth)acrylic monomer, and a radical polymerization initiator, with specific formulations of these components to enhance adhesiveness.
The composition achieves excellent adhesiveness, enabling strong bonding in various applications.
Smart Images

Figure 2024158937000001 
Figure 2024158937000002 
Figure 2024158937000003
Abstract
Description
[Technical field]
[0001] The present disclosure relates to a curable composition comprising a fluorine-containing compound. [Background technology]
[0002] It is known that compositions containing certain types of fluorine-containing compounds give cured products having excellent water repellency, oil repellency, stain resistance, and the like (Patent Documents 1 and 2). [Prior art documents] [Patent documents]
[0003] [Patent Document 1] JP 2019-6843 A [Patent Document 2] International Publication No. 2019 / 088126 Summary of the Invention [Problem to be solved by the invention]
[0004] An object of the present disclosure is to provide a curable composition having excellent adhesion. [Means for solving the problem]
[0005] The present disclosure includes the following aspects. [1] Component (A): A compound containing a fluoropolyether group, Component (B): (meth)acrylic monomer, and Component (C): Radical polymerization initiator Including, The fluoropolyether group-containing compound is represented by the following formula (A1) or (A2): [ka] [In formula: R F2 are each independently -Rf 2 p -R F -O q- and Rf 2 C may be substituted with one or more fluorine atoms. 1-6 is an alkylene group, R F are each independently a divalent fluoropolyether group; p is 0 or 1; Each q is independently 0 or 1; X A are each independently a single bond or a divalent organic group, X B are each independently a (m+1)-valent group, However, in each formula, at least one X B is a (m+1)-valent group containing a hydrolyzable silyl group, R Ac are each independently -X D -X E (-X F -OCO-CR 5 =CH2) m’ and X D is a single bond or a divalent group, X E is a single bond or a group having a valence of (m'+1), X F are each independently a single bond or a divalent group, R 5 is a hydrogen atom, a halogen atom, or a monovalent organic group having 1 to 8 carbon atoms, m' is an integer from 1 to 10, m is independently an integer of 0 to 10, R a are each independently an (m3+2)-valent organic group, m3 is an integer from 0 to 4, However, at least one of m and m3 is 1 or more, R g are each independently -NR c CO-R e -, -NR c COO-R e - or -NRc CONR c -R e -, where the left side of these groups is R a Binds to R c are each independently a hydrogen atom, C 1-6 Alkyl group or C 6-16 is an aryl group, R e are each independently a single bond or a divalent organic group, x is an integer equal to or greater than 1. A curable composition comprising at least one compound represented by the following formula: [2] The curable composition according to the above [1], wherein the content of component (A) is 60 mass% or more based on the total amount of components (A) and (B). [3] The curable composition according to the above [1] or [2], wherein the content of component (A) is 80 mass% or more based on the total amount of component (A) and component (B). [4] R F are each independently represented by the formula: -(OC6F 12 ) a -(OC5F 10 ) b -(OC4F8) c -(OC3R Fa 6) d -(OC2F4) e -(OCF2) f - [In the formula, R Fa each independently represents a hydrogen atom, a fluorine atom, or a chlorine atom, a, b, c, d, e, and f each independently represent an integer of 0 to 200, the sum of a, b, c, d, e, and f is 1 or more, and the order of the repeating units enclosed in parentheses with a, b, c, d, e, or f is arbitrary in the formula, provided that all R Fa is a hydrogen atom or a chlorine atom, at least one of a, b, c, e and f is 1 or greater.] The curable composition according to any one of the above [1] to [3], wherein the group is represented by the following formula: [5] R Fare each independently represented by the following formula (f1), (f2), (f3), (f4), (f5), or (f6): -(OC3F6) d -(OC2F4) e - (f1) [In the formula, d is an integer of 1 to 200, and e is 0 or 1.] -(OC4F8) c -(OC3F6) d -(OC2F4) e -(OCF2) f - (f2) [In the formula, c and d each independently represent an integer of 0 to 30; e and f each independently represent an integer of 1 to 200; The sum of c, d, e, and f is an integer of 10 to 200; The order of occurrence of each repeat unit enclosed in parentheses with the subscript c, d, e, or f is arbitrary in the formula. -(R 6 -R 7 ) g - (f3) [In the formula, R 6 is OCF2 or OC2F4; R 7 are OC2F4, OC3F6, OC4F8, OC5F 10 and OC6F 12 or a combination of two or three groups selected from these groups; g is an integer from 2 to 100. -(R 6 -R 7 ) g -R r -(R 7’ -R 6’ ) g’ - (f4) [In the formula, R 6 is OCF2 or OC2F4, R 7 are OC2F4, OC3F6, OC4F8, OC5F 10 and OC6F 12or a combination of two or three groups independently selected from these groups; R 6’ is OCF2 or OC2F4, R 7’ are OC2F4, OC3F6, OC4F8, OC5F 10 and OC6F 12 or a combination of two or three groups independently selected from these groups; g is an integer from 2 to 100; g' is an integer from 2 to 100, R r teeth, [ka] (In the formula, * indicates the bond position.) ]; -(OC6F 12 ) a -(OC5F 10 ) b -(OC4F8) c -(OC3F6) d -(OC2F4) e -(OCF2) f - (f5) [In the formula, e is an integer of 1 or more and 200 or less, a, b, c, d, and f are each independently an integer of 0 or more and 200 or less, the sum of a, b, c, d, e, and f is at least 1, and the order of the repeating units enclosed in parentheses with a, b, c, d, e, or f is arbitrary in the formula.] -(OC6F 12 ) a -(OC5F 10 ) b -(OC4F8) c -(OC3F6) d -(OC2F4) e -(OCF2) f - (f6) [In the formula, f is an integer of 1 or more and 200 or less, a, b, c, d, and e are each independently an integer of 0 or more and 200 or less, the sum of a, b, c, d, e, and f is at least 1, and the order of the repeating units enclosed in parentheses with a, b, c, d, e, or f is arbitrary in the formula.] The curable composition according to any one of the above [1] to [4], wherein the group is represented by the following formula: [6] X E The curable composition according to any one of the above [1] to [5], wherein is a single bond. [7] X E -X G -X H and X G teeth, Single bond, C 1-6 An alkylene group, -(CH2) z9 -O-(CH2) z10 - (wherein z9 is an integer from 0 to 6, and z10 is an integer from 0 to 6), or -(CH2) z11 -Phenylene-(CH2) z12 (wherein z11 is an integer of 0 to 6, and z12 is an integer of 0 to 6). and X H is as follows: [ka] and R 8 is a hydrogen atom or C 1-6 is an alkyl group, The curable composition according to any one of the above items [1] to [6]. [8] X D -O-, -CO-, -COO-, -OCO-, -CONH-, -NHCO-, -OCONH-, -NHCOO-, -NH-CO-NH-, -CH2CH(OH)CH2-, -CH(CH2OH)CH2-, -(OSiR 14 2) d5 -, [ka] [In the formula, * and ** indicate bond positions, * indicates X B , ** is X E Binds to .] and R 14 is C 1-6 Alkyl group or C 6-16 is an aryl group, The curable composition according to any one of the above [1] to [7], wherein d5 is an integer of 1 to 10. [9] X F teeth, Single bond, C 1-6 An alkylene group, -(CH2) z5 -O-(CH2) z6 - (wherein z5 is an integer from 0 to 6, and z6 is an integer from 0 to 6), or -(CH2) z7 -Phenylene-(CH2) z8 - (wherein z7 is an integer of 0 to 6, and z8 is an integer of 0 to 6). The curable composition according to any one of the above [1] to [8],
[10] R 5 The curable composition according to any one of the above [1] to [9], wherein is a hydrogen atom or a methyl group.
[11] X A each independently represents a single bond, or -(C α R 11 2α ) s1 -R 12 t1 - [In formula: R 11 are each independently a hydrogen atom or a fluorine atom, Each a is independently an integer from 1 to 10, R 12 are each independently -O-, -CO-, or -NR 10 -,-CONR 10 -, -NR 10-CO-, -COO-, -OCO-, or -OCONH-; R 10 is a hydrogen atom or C 1-6 is an alkyl group, s1 is an integer from 0 to 3, t1 is an integer from 0 to 3, The sum of s1 and t1 is greater than or equal to 1, The order of occurrence of each repeating unit enclosed in parentheses with s1 or t1 is arbitrary in the formula. The curable composition according to any one of the above [1] to
[10] , wherein the group is represented by the following formula:
[12] X A -CONR 10 -C α1 H 2α1 -, -(C α2 H 2α2 )-OCONR 10 -, -(C α3 H 2α3 )- or -(C α4 H 2α4 )-O-(C α5 H 2α5 ) and R 10 is a hydrogen atom or C 1-6 is an alkyl group, α1 is an integer from 1 to 10, α2 is an integer from 1 to 10, α3 is an integer from 1 to 10, α4 is an integer from 0 to 6, α5 is an integer from 0 to 6; The curable composition according to any one of the above items [1] to
[10] .
[13] X B are each independently SiR 1 nb R sb 4-nb [In formula: R 1 is a hydroxyl group or a hydrolyzable group, R sb is a single bond, nb is 1 or 2. A group containing a group represented by the formula: The curable composition according to any one of the above items [1] to
[12] .
[14] X B are each independently Ba (R Si ) na [In formula: X Ba are each independently a (m+na+1)-valent group, R Si are each independently -X C -SiR 1 n’ R 2 3-n’ and X C is a divalent organic group having 1 to 10 carbon atoms, R 1 are each independently a hydroxyl group or a hydrolyzable group, R 2 each independently represents a hydrogen atom or a monovalent organic group, n' is an integer from 1 to 3; and na is an integer from 1 to 10. The curable composition according to any one of the above [1] to
[12] , wherein the group is represented by the following formula:
[15] X C teeth, C 1-6 An alkylene group, -(CH2) z1 -O-(CH2) z2 - (wherein z1 is an integer from 0 to 6, and z2 is an integer from 0 to 6), -(CH2) z3 -Phenylene-(CH2) z4 - (wherein z3 is an integer of 0 to 6, and z4 is an integer of 0 to 6), or -(CH2) z13 -OCONH-(CH2) z14 (wherein z13 is an integer of 0 to 6, and z14 is an integer of 0 to 6). The curable composition according to the above
[14] ,
[16] The curable composition according to
[14] above, wherein n' is 3.
[17] X Ba is a trivalent group, n is 1, and m is 1.
[18] X Ba is N or -C(-O-)-, n is 1, and m is 1.
[19] Equation (A2) is [ka] [In the formula, R b are each independently R Si , R Ac , or R c and However, R b At least one of the following is R Si and R Si are each independently -X C -SiR 1 n’ R 2 3-n’ and X C is a divalent organic group having 1 to 10 carbon atoms, R 1 are each independently a hydroxyl group or a hydrolyzable group, R 2 each independently represents a hydrogen atom or a monovalent organic group, n' is an integer from 1 to 3; R d are each independently a single bond or a divalent organic group, R F2 , R a , R c , R Ac , m3, and x are defined as above in [1]. The curable composition according to any one of the above [1] to
[18] ,
[20] R bonded to the N atom at each end in formula (A2) b One of them is R Siand the other is R c or R Ac The curable composition according to
[19] above,
[21] R d are each independently a single bond or -(CH2) z17 -NR 10 -(CH2) z18 -(In the formula, R 10 is a hydrogen atom or C 1-6 z17 is an integer of 0 to 6, and z18 is an integer of 0 to 6.
[22] R a are each independently represented by the following formula: -R 9 -(R a’ -R 9 ) k - [In formula: R 9 are each independently 1-6 is an alkylene group, R a’ are each independently a trivalent group, k is an integer from 1 to 4. The curable composition according to any one of the above [1] to
[21] , wherein the group is represented by the following formula:
[23] R a’ each independently represents N, -C(-O-)-, or a trivalent group which may contain an amino bond, an amide bond, a urethane bond, a urea bond, an ether bond, or an ester bond between carbon atoms.
[24] The curable composition according to
[22] above, wherein k is 1 or 2.
[25] R c are each independently a hydrogen atom or C 1-6 The curable composition according to any one of the above [1] to
[24] , wherein the group is an alkyl group.
[26] The curable composition according to any one of the above [1] to
[25] , wherein x is an integer of 1 or more and 5 or less.
[27] The curable composition according to any one of the above [1] to
[26] , wherein the fluoropolyether group-containing compound comprises a compound represented by formula (A1):
[28] The curable composition according to any one of the above [1] to
[26] , wherein the fluoropolyether group-containing compound comprises a compound represented by formula (A2):
[29] The curable composition according to any one of the above [1] to
[28] , wherein the (meth)acrylic monomer is (a) a urethane (meth)acrylate, (b) an epoxy (meth)acrylate, (c) a polyester (meth)acrylate, (d) a polyether (meth)acrylate, (e) a silicone (meth)acrylate, or (f) a (meth)acrylate monomer.
[30] The curable composition according to any one of the above [1] to
[29] , wherein the radical polymerization initiator is a diketone, an acyloin, an acyloin ether, a thioxanthone, a benzophenone, an acetophenone, a quinone, an aminobenzoic acid, a halogen compound, an acylphosphine oxide, or a peroxide.
[31] The radical polymerization initiator may be benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, thioxanthone, 2,4-diethylthioxanthone, thioxanthone-4-sulfonic acid, benzophenone, 4,4'-bis(dimethylamino)benzophenone, 4,4'-bis(diethylamino)benzophenone, acetophenone, 2-(4-toluenesulfonyloxy)-2-phenylacetophenone, p-dimethylaminoacetophenone, 2,2'-dimethoxy-2-phenylacetophenone, p-Methoxyacetophenone, 2-methyl[4-(methylthio)phenyl]-2-morpholino-1-propanone, 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butan-1-one, anthraquinone, 1,4-naphthoquinone, ethyl 2-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate, (n-butoxy)ethyl 4-dimethylaminobenzoate, isoamyl 4-dimethylaminobenzoate, 2-ethylhexyl 4-dimethylaminobenzoate, phenacyl chloride, trihalomethylphenylsulfone , acylphosphine oxide, or di-t-butyl peroxide, methyl benzoyl formate, 1-hydroxy-cyclohexyl-phenyl-ketone, 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propan-1-one, 2-hydroxy-1-{4-[4-(2-hydroxy-2-methyl-propionyl)-benzyl]phenyl}-2-methyl-propan-1-one, 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one, 2-benzyl-2-dimethyl 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(4-morpholinyl)phenyl]-1-butanone, bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide, bis(η5-2,4-cyclopentadiene-1-yl)-bis(2,6-difluoro-3-(1H-pyrrol-1-yl)-phenyl)titanium, 1,2-octanedione, 1-[4-(phenylthio)-, 2-(O-benzoyloxime)], ethanone,The curable composition according to any one of the above [1] to
[30] , which is 1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]-, 1-(0-acetyloxime), 2-hydroxy-2-methyl-1-phenyl-propan-1-one, 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide, t-butyl hydroperoxide, cumene hydroperoxide, diisopropylbenzene hydroperoxide, permentha hydroperoxide, or t-methylbutyl hydroperoxide.
[32] The curable composition according to any one of the above [1] to
[31] , further comprising a solvent.
[33] A cured product obtained from the curable composition according to any one of the above [1] to
[32] .
[34] An article comprising a substrate and a layer formed on a surface of the substrate from the curable composition according to any one of the above [1] to
[32] . Effect of the Invention
[0006] According to the present disclosure, it is possible to provide a curable composition having excellent adhesion. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0007] As used herein, the term "monovalent organic group" refers to a monovalent group containing carbon. The monovalent organic group is not particularly limited, but may be a hydrocarbon group or a derivative thereof. The derivative of a hydrocarbon group refers to a group having one or more N, O, S, Si, amide, sulfonyl, siloxane, carbonyl, carbonyloxy, etc. at the end or in the molecular chain of the hydrocarbon group. In addition, when simply referring to an "organic group", it refers to a monovalent organic group. In addition, the term "divalent organic group" refers to a divalent group containing carbon. Examples of such divalent organic groups include divalent groups obtained by further removing one hydrogen atom from an organic group. Similarly, a trivalent or higher organic group refers to a group obtained by removing a predetermined number of hydrogen atoms from an organic group.
[0008] As used herein, the term "hydrocarbon group" refers to a group containing carbon and hydrogen, which is a group obtained by removing a hydrogen atom from a hydrocarbon. Such a hydrocarbon group includes, but is not limited to, C 1-20 Examples of the hydrocarbon group include an aliphatic hydrocarbon group and an aromatic hydrocarbon group. The "aliphatic hydrocarbon group" may be linear, branched, or cyclic, and may be saturated or unsaturated. The hydrocarbon group may contain one or more ring structures. The hydrocarbon group may be substituted with one or more substituents.
[0009] As used herein, examples of the substituent of the "hydrocarbon group" include, but are not limited to, a halogen atom, a C 1-6 Alkyl group, C 2-6 Alkenyl group, C 2-6 Alkynyl group, C 3-10 Cycloalkyl groups, C 3-10 Unsaturated cycloalkyl groups, 5-10 membered heterocyclyl groups, 5-10 membered unsaturated heterocyclyl groups, C 6-10 Examples of the alkyl group include one or more groups selected from an aryl group and a 5- to 10-membered heteroaryl group.
[0010] As used herein, the term "hydrolyzable group" refers to a group that can undergo hydrolysis, i.e., a group that can be removed from the main skeleton of a compound by hydrolysis. Examples of hydrolyzable groups include -OR j , -OCOR j , -ON=CR j 2, -NR j 2, -NHR j , -NCO, -NCO, or halogen (wherein R j is a substituted or unsubstituted C 1-4 (representing an alkyl group) and the like.
[0011] The curable composition of the present disclosure comprises: Component (A): a fluoropolyether group-containing compound, Component (B): (meth)acrylic monomer, and Component (C): Radical polymerization initiator Includes.
[0012] Component (A): Fluoropolyether group-containing compound
[0013] The fluoropolyether group-containing compound contained in the curable composition of the present disclosure contains a (meth)acrylic group, a hydrolyzable silane group, and a fluoropolyether group. The curable composition of the present disclosure has excellent curability by containing the fluoropolyether group-containing compound. In this specification, (meth)acrylic includes acrylic and methacrylic.
[0014] The fluoropolyether group-containing compound is represented by the following formula (A1) or (A2): [ka] [In formula: R F2 are each independently -Rf 2 p -R F -O q - and Rf 2 C may be substituted with one or more fluorine atoms. 1-6 is an alkylene group, R F are each independently a divalent fluoropolyether group; p is 0 or 1; Each q is independently 0 or 1; X A are each independently a single bond or a divalent organic group, X B are each independently a (m+1)-valent group, However, in each formula, at least one X B is a (m+1)-valent group containing a hydrolyzable silyl group, R Ac are each independently -X D -XE (-X F -OCO-CR 5 =CH2) m’ and X D is a single bond or a divalent group, X E is a single bond or a group having a valence of (m'+1), X F are each independently a single bond or a divalent group, R 5 is a hydrogen atom, a halogen atom, or a monovalent organic group having 1 to 8 carbon atoms, m' is an integer from 1 to 10, m is independently an integer of 0 to 10, R a are each independently an (m3+2)-valent organic group, m3 is an integer from 0 to 4, However, at least one of m and m3 is 1 or more, R g are each independently -NR c CO-R e -, -NR c COO-R e - or -NR c CONR c -R e -, where the left side of these groups is R a Binds to R c are each independently a hydrogen atom, C 1-6 Alkyl group or C 6-16 is an aryl group, R e are each independently a single bond or a divalent organic group, x is an integer equal to or greater than 1. The compound includes at least one of the compounds represented by the formula:
[0015] The fluoropolyether group-containing compound preferably contains a (meth)acrylic group and a hydrolyzable silane group at both ends thereof. That is, X B is a group containing a hydrolyzable silyl group.
[0016] In one embodiment, the fluoropolyether group-containing compound includes a compound represented by formula (A1). For example, the fluoropolyether group-containing compound is a compound represented by formula (A1).
[0017] In one embodiment, the fluoropolyether group-containing compound includes a compound represented by formula (A2). For example, the fluoropolyether group-containing compound is a compound represented by formula (A2).
[0018] In one embodiment, the fluoropolyether group-containing compound includes a compound represented by formula (A1) and a compound represented by formula (A2). For example, the fluoropolyether group-containing compound is a compound represented by formula (A1) and a compound represented by formula (A2).
[0019] In the above formulas (A1) and (A2), R F2 is -Rf 2 p -R F -O q -It is.
[0020] In the above formula, Rf 2 each independently represents a C which may be substituted by one or more fluorine atoms; 1-6 It is an alkylene group.
[0021] C which may be substituted by one or more fluorine atoms 1-6 "C" in the alkylene group 1-6 The "alkylene group" may be a straight chain or a branched chain, and is preferably a straight chain or branched chain C 1-3 It is preferably a linear alkylene group. 1-3 It is an alkylene group.
[0022] Above Rf 2 is preferably C substituted by one or more fluorine atoms 1-6 is an alkylene group, more preferably C 1-6A perfluoroalkylene group, more preferably C 1-3 It is a perfluoroalkylene group.
[0023] Above C 1-6 The perfluoroalkylene group may be linear or branched, and is preferably a linear or branched C 1-3 A perfluoroalkylene group, more preferably a linear C 1-3 A perfluoroalkyl group, specifically, -CF2-, -CF2CF2-, or -CF2CF2CF2-.
[0024] In the above formula, p is 0 or 1. In one embodiment, p is 0. In another embodiment, p is 1.
[0025] In the above formula, each q is independently 0 or 1. In one embodiment, q is 0. In another embodiment, q is 1.
[0026] In the above formulas (A1) to (A2), R F are each independently a divalent fluoropolyether group.
[0027] R F is preferably a linear divalent fluoropolyether group. By using a linear divalent fluoropolyether group, the viscosity becomes relatively low, and the coating property and handling property are improved.
[0028] R F is preferably of the formula: -(OC6F 12 ) a -(OC5F 10 ) b -(OC4F8) c -(OC3R Fa 6) d -(OC2F4) e -(OCF2) f - [In formula: R Fa each independently represents a hydrogen atom, a fluorine atom, or a chlorine atom, a, b, c, d, e, and f are each independently an integer of 0 to 200, and the sum of a, b, c, d, e, and f is 1 or more. The order of the repeating units enclosed in parentheses with a, b, c, d, e, or f is arbitrary in the formula. However, all R Fa is a hydrogen atom or a chlorine atom, at least one of a, b, c, e and f is 1 or greater.] It is a group represented by the following formula:
[0029] R Fa is preferably a hydrogen atom or a fluorine atom, more preferably a fluorine atom. However, all R Fa is a hydrogen atom or a chlorine atom, at least one of a, b, c, e and f is 1 or greater.
[0030] Preferably, a, b, c, d, e and f may each independently be an integer of 0 to 100.
[0031] The sum of a, b, c, d, e and f is preferably 5 or more, more preferably 10 or more, and may be, for example, 15 or more or 20 or more. The sum of a, b, c, d, e and f is preferably 200 or less, more preferably 100 or less, and even more preferably 60 or less, and may be, for example, 50 or less or 30 or less.
[0032] These repeating units may be linear or branched, and may contain a ring structure. For example, -(OCF 12 )- may be -(OCF2CF2CF2CF2CF2CF2CF2)-, -(OCF(CF3)CF2CF2CF2CF2)-, -(OCF2CF(CF3)CF2CF2CF2)-, -(OCF2CF2CF(CF3)CF2CF2)-, -(OCF2CF2CF2CF(CF3)CF2)-, -(OCF2CF2CF2CF2CF(CF3)CF2)-, -(OCF2CF2CF2CF2CF(CF3))-, etc. 10)- may be -(OCF2CF2CF2CF2CF2)-, -(OCF(CF3)CF2CF2CF2)-, -(OCF2CF(CF3)CF2CF2)-, -(OCF2CF2CF(CF3)CF2)-, -(OCF2CF2CF2CF(CF3))-, etc. -(OC4F8)- may be any of -(OCF2CF2CF2CF2)-, -(OCF(CF3)CF2CF2)-, -(OCF2CF(CF3)CF2)-, -(OCF2CF2CF(CF3))-, -(OC(CF3)2CF2)-, -(OCF2C(CF3)2)-, -(OCF(CF3)CF(CF3))-, -(OCF(C2F5)CF2)-, and -(OCF2CF(C2F5))-. -(OC3F6)- (i.e., in the above formula, R Fa is a fluorine atom) may be any of -(OCF2CF2CF2)-, -(OCF(CF3)CF2)-, and -(OCF2CF(CF3))-. -(OC2F4)- may be any of -(OCF2CF2)- and -(OCF(CF3))-.
[0033] The ring structure may be a three-, four-, five-, or six-membered ring as described below. [ka] [In the formula, * indicates the bond position.]
[0034] The ring structure may be preferably a four-, five-, or six-membered ring, more preferably a four-, or six-membered ring.
[0035] The repeating unit having a ring structure may preferably be the following unit. [ka] [In the formula, * indicates the bond position.]
[0036] In one embodiment, the repeating unit is linear. By making the repeating unit linear, the durability and the like of the cured layer can be improved.
[0037] In one embodiment, the repeat unit is branched.
[0038] In one embodiment, R F are each independently a group represented by any one of the following formulas (f1) to (f6). -(OC3F6) d -(OC2F4) e - (f1) [In the formula, d is an integer of 1 to 200, and e is 0 or 1, preferably 1.] -(OC4F8) c -(OC3F6) d -(OC2F4) e -(OCF2) f - (f2) [In the formula, c and d each independently represent an integer of 0 or more and 30 or less, and e and f each independently represent an integer of 1 or more and 200 or less, The sum of c, d, e, and f is 2 or more, The order of occurrence of each repeat unit enclosed in parentheses with the subscript c, d, e, or f is arbitrary in the formula. -(R 6 -R 7 ) g - (f3) [In the formula, R 6 is OCF2 or OC2F4, R 7 are OC2F4, OC3F6, OC4F8, OC5F 10 and OC6F 12 or a combination of two or three groups independently selected from these groups; g is an integer from 2 to 100; -(R 6 -R 7 ) g -R r -(R 7’ -R 6’ ) g’ - (f4) [In the formula, R 6 is OCF2 or OC2F4, R 7are OC2F4, OC3F6, OC4F8, OC5F 10 and OC6F 12 or a combination of two or three groups independently selected from these groups; R 6’ is OCF2 or OC2F4, R 7’ are OC2F4, OC3F6, OC4F8, OC5F 10 and OC6F 12 or a combination of two or three groups independently selected from these groups; g is an integer from 2 to 100; g' is an integer from 2 to 100, R r teeth, [ka] (In the formula, * indicates the bond position.) ]; -(OC6F 12 ) a -(OC5F 10 ) b -(OC4F8) c -(OC3F6) d -(OC2F4) e -(OCF2) f - (f5) [In the formula, e is an integer of 1 or more and 200 or less, a, b, c, d, and f are each independently an integer of 0 or more and 200 or less, and the order of the repeating units enclosed in parentheses with a, b, c, d, e, or f is arbitrary in the formula.] -(OC6F 12 ) a -(OC5F 10 ) b -(OC4F8) c -(OC3F6) d -(OC2F4) e -(OCF2) f - (f6) [In the formula, f is an integer of 1 or more and 200 or less, a, b, c, d, and e are each independently an integer of 0 or more and 200 or less, and the order of the repeating units enclosed in parentheses with a, b, c, d, e, or f is arbitrary in the formula.]
[0039] In the above formula (f1), d is preferably an integer of 5 to 200, more preferably 10 to 100, further preferably 15 to 50, for example, an integer of 25 to 35. In one embodiment, e is 1. In another embodiment, e is 0. In the above formula (f1), (OC3F6) is preferably a group represented by (OCF2CF2CF2), (OCF2CF(CF3)) or (OCF(CF3)CF2), and more preferably -(OCF2CF2CF2) d In the above formula (f1), (OC2F4) is preferably a group represented by (OCF2CF2) or (OCF(CF3)), and more preferably a group represented by (OCF2CF2).
[0040] In the above formula (f2), e and f are each independently an integer of preferably 5 to 200, more preferably 10 to 200. The sum of c, d, e and f is preferably 5 or more, more preferably 10 or more, and may be, for example, 15 or more or 20 or more. In one embodiment, the above formula (f2) is preferably -(OCF2CF2CF2CF2) c -(OCF2CF2CF2) d -(OCF2CF2) e -(OCF2) f In another embodiment, formula (f2) is a group represented by -(OC2F4) e -(OCF2) f - may be a group represented by the formula:
[0041] In the above formula (f3), R 6 is preferably OC2F4. In the above (f3), R 7is preferably a group selected from OC2F4, OC3F6 and OC4F8, or a combination of two or three groups independently selected from these groups, and more preferably a group selected from OC3F6 and OC4F8. The combination of two or three groups independently selected from OC2F4, OC3F6 and OC4F8 is not particularly limited, and examples thereof include -OC2F4OC3F6-, -OC2F4OC4F8-, -OC3F6OC2F4-, -OC3F6OC3F6-, -OC3F6OC4F8-, -OC4F8OC4F8-, -OC4F8OC3F6-, -OC4F8OC2F4-, -OC Examples of the 2F4OC2F4OC3F6-, -OC2F4OC2F4OC4F8-, -OC2F4OC3F6OC2F4-, -OC2F4OC3F6OC3F6-, -OC2F4OC4F8OC2F4-, -OC3F6OC2F4OC2F4-, -OC3F6OC2F4OC3F6-, -OC3F6OC3F6OC2F4-, and -OC4F8OC2F4OC2F4- are mentioned. In the above formula (f3), g is preferably an integer of 3 or more, more preferably an integer of 5 or more. The above g is preferably an integer of 50 or less. In the above formula (f3), OC2F4, OC3F6, OC4F8, OC5F 10 and OC6F 12 may be either linear or branched, and is preferably linear. In this embodiment, the above formula (f3) is preferably -(OC2F4-OC3F6) g -or- (OC2F4-OC4F8) g -It is.
[0042] In the above formula (f4), R 6 , R 7 and g have the same meanings as those described in the above formula (f3) and have the same embodiments. 6’ , R 7’ and g' are R 6 , R 7 and g have the same meaning and behavior. r is preferably [ka] [In the formula, * indicates the bond position.] and more preferably [ka] [In the formula, * indicates the bond position.] It is.
[0043] In the above formula (f5), e is preferably an integer of 1 or more and 100 or less, more preferably an integer of 5 or more and 100 or less. The sum of a, b, c, d, e and f is preferably 5 or more, more preferably 10 or more, for example, 10 or more and 100 or less.
[0044] In the above formula (f6), f is preferably an integer of 1 or more and 100 or less, more preferably an integer of 5 or more and 100 or less. The sum of a, b, c, d, e and f is preferably 5 or more, more preferably 10 or more, for example, 10 or more and 100 or less.
[0045] In one embodiment, the R F is a group represented by the above formula (f1) or (f2).
[0046] In one embodiment, the R F is a group represented by the above formula (f1).
[0047] In one embodiment, the R F is a group represented by the above formula (f2).
[0048] In one embodiment, the R F is a group represented by the above formula (f3) or (f4).
[0049] In one embodiment, the R F is a group represented by the above formula (f3).
[0050] In one embodiment, the R F is a group represented by the above formula (f4).
[0051] In one embodiment, the RF is a group represented by the above formula (f5).
[0052] In one embodiment, the R F is a group represented by the above formula (f6).
[0053] Above R F In the formula, the ratio of e to f (hereinafter referred to as "e / f ratio") is 0.1 to 10, preferably 0.2 to 5, more preferably 0.2 to 2, even more preferably 0.2 to 1.5, and even more preferably 0.2 to 0.85. By setting the e / f ratio to 10 or less, the durability and chemical resistance (e.g., durability against artificial sweat) of the cured layer obtained from this compound are further improved. The smaller the e / f ratio, the more improved the durability and chemical resistance of the cured layer. On the other hand, by setting the e / f ratio to 0.1 or more, the stability of the compound can be further improved. The larger the e / f ratio, the more improved the stability of the compound.
[0054] In one embodiment, the e / f ratio is preferably 0.2 to 0.95, and more preferably 0.2 to 0.9.
[0055] In one embodiment, from the viewpoint of heat resistance, the e / f ratio is preferably 1.0 or more, and more preferably 1.0 to 2.0.
[0056] In the above fluoropolyether group-containing compound, R F2 The number average molecular weight of the portion is not particularly limited, but is, for example, 500 to 30,000, preferably 1,500 to 30,000, and more preferably 2,000 to 10,000. F2 The number average molecular weight of 19 The value is measured by F-NMR.
[0057] In the above formulas (A1) and (A2), R Ac are each independently -X D -X E (-X F -OCO-CR5 =CH2) m’ It is.
[0058] Above X D is a single bond or a divalent group, such as a divalent organic group.
[0059] X D is preferably -O-, -CO-, -COO-, -OCO-, -CONH-, -NHCO-, -OCONH-, -NHCOO-, -NH-CO-NH-, -CHCH(OH)CH-, -CH(CHOH)CH-, -(OSiR 14 2) d5 -, [ka] [In the formula, * and ** indicate bond positions, * indicates X B , ** is X E Binds to .] and R 14 is C 1-6 Alkyl group or C 6-16 is an aryl group, d5 is an integer from 1 to 10. These groups are represented by the formula: B Bind to.
[0060] X D is more preferably -CONH-, -CHCH(OH)CH-, or -CH(CHOH)CH-, more preferably -CONH-.
[0061] Above X E is a single bond or a group having a valence of (m'+1).
[0062] In one embodiment, X E is a single bond.
[0063] In one embodiment, X E teeth, -X G -X H [In formula: X Gteeth, Single bond, C 1-6 An alkylene group, -(CH2) z9 -O-(CH2) z10 - (wherein z9 is an integer of 0 to 6, for example an integer of 1 to 6, and z10 is an integer of 0 to 6, for example an integer of 1 to 6), or -(CH2) z11 -Phenylene-(CH2) z12 - (wherein z11 is an integer of 0 to 6, for example, an integer of 1 to 6, and z12 is an integer of 0 to 6, for example, an integer of 1 to 6). and X H is as follows: [ka] and R 8 is a hydrogen atom or C 1-6 is an alkyl group. It is a tri- or tetravalent group represented by the following formula:
[0064] Above C 1-6 The alkylene group may be straight-chained or branched, but is preferably straight-chained.
[0065] In a preferred embodiment, the above C 1-6 The alkylene group is C 2-4 It is an alkylene group.
[0066] Above C 1-6 The alkyl group is preferably C 1-3 It is preferably an alkyl group, more preferably a methyl group.
[0067] Above X F are each independently a single bond or a divalent group, for example, a divalent organic group (preferably a divalent organic group having 1 to 10 carbon atoms).
[0068] In one embodiment, X F teeth, Single bond, C 1-6An alkylene group, -(CH2) z5 -O-(CH2) z6 - (wherein z5 is an integer of 0 to 6, for example, an integer of 1 to 6, and z6 is an integer of 0 to 6, for example, an integer of 1 to 6), or -(CH2) z7 -Phenylene-(CH2) z8 - (wherein z7 is an integer of 0 to 6, for example, an integer of 1 to 6, and z8 is an integer of 0 to 6, for example, an integer of 1 to 6). These groups are, for example, fluorine atoms, C 1-6 Alkyl group, C 2-6 Alkenyl groups, and C 2-6 These groups are preferably unsubstituted, but may be substituted with one or more substituents selected from alkynyl groups. B Bind to.
[0069] Above C 1-6 The alkylene group may be straight-chained or branched, but is preferably straight-chained.
[0070] In a preferred embodiment, X F is C 1-6 Alkylene group, preferably C 2-4 It is an alkylene group.
[0071] In one embodiment, X D , X E , and X F is a single bond.
[0072] Above R 5 is a hydrogen atom, a halogen atom, or a monovalent organic group having 1 to 8 carbon atoms.
[0073] The monovalent organic group is preferably C 1-8 Alkyl group, C 3-8 Cycloalkyl group or C 5-8 is an aryl group, more preferably C 1-6 is an alkyl group or a phenyl group, more preferably C 1-3It is an alkyl group, and particularly preferably a methyl group.
[0074] In one embodiment, R 5 is a hydrogen atom.
[0075] In one embodiment, R 5 is a methyl group.
[0076] The above m' is an integer of 1 to 10, preferably an integer of 1 to 3, and more preferably 1.
[0077] In the above formulas (A1) and (A2), X A are each independently a single bond or a divalent organic group.
[0078] In one embodiment, X A are each independently a single bond or a divalent organic group that does not contain a urethane bond, a polyisocyanate structure, or a siloxane bond.
[0079] In a preferred embodiment, X A each independently represents a single bond, or -(C α R 11 2α ) s1 -R 12 t1 - [In formula: R 11 are each independently a hydrogen atom or a fluorine atom, Each a is independently an integer from 1 to 10, R 12 are each independently -O-, -CO-, -CONH-, -NHCO-, -COO-, -OCO-, or -OCONH-; s1 is an integer from 0 to 3, t1 is an integer from 0 to 3, The sum of s1 and t1 is greater than or equal to 1, The order of occurrence of each repeating unit enclosed in parentheses with s1 or t1 is arbitrary in the formula. In the formula, the left side is R F2 Bind to.
[0080] In one embodiment, X A is a single bond.
[0081] In one embodiment, X A are each independently the above-(C α R 11 2α ) s1 -R 12 t1 -It is.
[0082] Above R 11 is preferably a hydrogen atom.
[0083] The above α's are each independently preferably an integer of 1 to 6, more preferably an integer of 1 to 4, and further preferably an integer of 2 to 4.
[0084] Above R 12 are each independently preferably -O-, -CO-, -NR 10 -, -CONH-, or -COO-, more preferably -CONH-.
[0085] Above R 10 is a hydrogen atom or C 1-6 It is an alkyl group, and preferably a hydrogen atom.
[0086] The above s1 is preferably an integer of 1 to 3, more preferably 1 or 2, and further preferably 1.
[0087] The above t1 is preferably an integer of 0 to 2, more preferably 1 or 2, and further preferably 1.
[0088] In a preferred embodiment, R 11 is a hydrogen atom, α is an integer from 2 to 4, R 12 -O-, -CO-, -NR10 -, -CONH-, or -COO-; R 10 is a hydrogen atom or C 1-6 is an alkyl group, s1 is 1 or 2; t1 is 0 or 1.
[0089] In a more preferred embodiment, X A -CONR 10 -C α1 H 2α1 -, -(C α2 H 2α2 )-OCONR 10 -, -(C α3 H 2α3 )- or -(C α4 H 2α4 )-O-(C α5 H 2α5 ) and R 10 is a hydrogen atom or C 1-6 is an alkyl group, α1 is an integer from 1 to 10, α2 is an integer from 1 to 10, α3 is an integer from 1 to 10, α4 is an integer from 0 to 6, α5 is an integer from 0 to 6. The left side of the group is R F2 Bind to.
[0090] X A is preferably -CONH-C α H 2α Such groups are represented by the left side as R F2 Bind to.
[0091] Above C α1 H 2α1 is preferably (CH2) α1 It is.
[0092] Above C α2 H 2α2 is preferably (CH2) α2 It is.
[0093] Above C α3 H 2α3 is preferably (CH2) α3 It is.
[0094] Above C α4 H 2α4 is preferably (CH2) α4 It is.
[0095] Above C α5 H 2α5 is preferably (CH2) α5 It is.
[0096] In the above formulas (A1) and (A2), X B are each independently a (m+1)-valent group. However, in each formula, at least one X B is an (m+1)-valent group containing a hydrolyzable silyl group.
[0097] In one embodiment, X B are each independently a (m+1)-valent group containing a hydrolyzable silyl group.
[0098] In one embodiment, X B are each independently SiR 1 nb R sb 4-nb [In formula: R 1 is a hydroxyl group or a hydrolyzable group, R sb is a single bond, nb is 1 or 2. or a group containing a group represented by X Ba (R Si ) na [In formula: X Ba are each independently a (m+na+1)-valent group, R Si are each independently -X C -SiR 1n’ R 2 3-n’ and X C is a divalent organic group having 1 to 10 carbon atoms, R 1 are each independently a hydroxyl group or a hydrolyzable group, R 2 each independently represents a hydrogen atom or a monovalent organic group, n' is an integer from 1 to 3; and na is an integer from 1 to 10. It is a group represented by the following formula:
[0099] In one embodiment, X B are each independently Ba (R Si ) na [In formula: X Ba are each independently a (m+na+1)-valent group, R Si are each independently -X C -SiR 1 n’ R 2 3-n’ and X C is a divalent organic group having 1 to 10 carbon atoms, R 1 are each independently a hydroxyl group or a hydrolyzable group, R 2 each independently represents a hydrogen atom or a monovalent organic group, n' is an integer from 1 to 3; and na is an integer from 1 to 10. It is a group represented by the following formula:
[0100] In such an embodiment, formula (A1) is represented by the following formula (A1-a): [ka] [In the formula, each symbol has the same meaning as above.] It is expressed as:
[0101] Above R Si are each independently -X C -SiR 1 n’ R 2 3-n’ It is.
[0102] Above X C is a divalent organic group having 1 to 10 carbon atoms.
[0103] In one embodiment, X C teeth, C 1-6 An alkylene group, -(CH2) z1 -O-(CH2) z2 - (wherein z1 is an integer of 0 to 6, for example, an integer of 1 to 6, and z2 is an integer of 0 to 6, for example, an integer of 1 to 6), -(CH2) z3 -Phenylene-(CH2) z4 - (wherein z3 is an integer of 0 to 6, for example, an integer of 1 to 6, and z4 is an integer of 0 to 6, for example, an integer of 1 to 6), or -(CH2) z13 -OCONH-(CH2) z14 (wherein z13 is an integer of 0 to 6, and z14 is an integer of 0 to 6). These groups are, for example, fluorine atoms, C 1-6 Alkyl group, C 2-6 Alkenyl groups, and C 2-6 These groups are preferably unsubstituted, but may be substituted with one or more substituents selected from alkynyl groups. B Bind to.
[0104] Above C 1-6 The alkylene group may be straight-chained or branched, but is preferably straight-chained.
[0105] In a preferred embodiment, X C is C 1-6 Alkylene group, preferably C 2-4 It is an alkylene group.
[0106] Above R 1 are each independently a hydroxyl group or a hydrolyzable group.
[0107] R 1 are preferably each independently a hydrolyzable group.
[0108] R 1 are preferably each independently -OR h , -OCOR h , -ON=CR h 2, -NR h 2, -NHR h , -NCO, or halogen (wherein R h is a substituted or unsubstituted C 1-4 alkyl group), more preferably -OR h (i.e., an alkoxy group). h Examples of R include unsubstituted alkyl groups such as methyl, ethyl, propyl, isopropyl, n-butyl, and isobutyl groups; and substituted alkyl groups such as chloromethyl. Among these, alkyl groups, particularly unsubstituted alkyl groups, are preferred, and methyl or ethyl groups are more preferred. In one embodiment, R h is a methyl group, and in another embodiment, R h is an ethyl group.
[0109] Above R 2 are each independently a hydrogen atom or a monovalent organic group. Such monovalent organic groups are monovalent organic groups excluding the above hydrolyzable groups.
[0110] R 2 In the above, the monovalent organic group is preferably C 1-20 is an alkyl group, more preferably C 1-6 It is preferably an alkyl group, more preferably a methyl group.
[0111] In the above formula, n' is (SiR 1 n’ R 2 3-n’) units each independently represents an integer of 1 to 3, preferably 2 or 3, and more preferably 3.
[0112] The above na is preferably an integer of 1 to 6, more preferably an integer of 1 to 3, and particularly preferably 1.
[0113] In one embodiment, the X Ba is a trivalent group, preferably [ka] In one embodiment, the -C(-O-)- is O is R Si In another embodiment, -C(-O-)- means that O is R Ac Bind to.
[0114] In a preferred embodiment, X Ba is N, where m is 1 and n is 1.
[0115] In another embodiment, X B are each independently 1 nb R sb 4-nb [In formula: R 1 is a hydroxyl group or a hydrolyzable group, R sb is a single bond, nb is 1 or 2. Preferably, the group represented by -X Bb -SiR 1 nb R sb 4-nb [In formula: X Bb is a single bond or a divalent group, R 1 is a hydroxyl group or a hydrolyzable group, R sb is a single bond, nb is 1 or 2. It is a group represented by the following formula:
[0116] In the above formulae (A1) and (A2), each m is independently an integer of 0 to 10, and each n is independently an integer of 1 to 10.
[0117] m is preferably an integer of 1 to 10, more preferably an integer of 1 to 6, even more preferably an integer of 1 to 3, and even more preferably 1.
[0118] n is preferably an integer of 1 to 6, more preferably an integer of 1 to 3, and particularly preferably 1.
[0119] In a preferred embodiment, m is 1 and n is 1.
[0120] In the above (A2), R a each independently represents an organic group having a valence of (m3+2).
[0121] In one embodiment, R a is expressed by the following formula: -R 9 -(R a’ -R 9 ) k - [In formula: R 9 are each independently 1-6 is an alkylene group, R a’ are each independently a trivalent group, for example a trivalent organic group; k is an integer from 1 to 4. In this group, the -C(-O-)- means that O is R Ac Bind to.
[0122] R 9 is preferably C 1-4 is an alkylene group, more preferably C 2-4 It is an alkylene group.
[0123] In one embodiment, k is 0.
[0124] In another embodiment, k is an integer from 1 to 4.
[0125] In a preferred embodiment, k is an integer of 1-2.
[0126] In one embodiment, k is 1.
[0127] In one embodiment, k is 2.
[0128] In one embodiment, R a’ are each independently a trivalent group containing a N atom or an O atom.
[0129] In a preferred embodiment, R a’ are each independently a trivalent group which may contain N, -C(-O-)-, or an amino bond, an amide bond, a urethane bond, a urea bond, an ether bond, or an ester bond between carbon atoms.
[0130] In one embodiment, R a’ are each independently one of the following groups: [ka] It is.
[0131] In one embodiment, R a’ is N.
[0132] In one embodiment, R a’ is -C(-O-)-.
[0133] In the above formula (A2), m3 is an integer of 0 to 4.
[0134] m3 is preferably an integer of 1 to 4, and more preferably 1 or 2.
[0135] In one embodiment, m3 is 1.
[0136] In one embodiment, m3 is 2.
[0137] In the above formula (A2), R g are each independently -NR c CO-R e -, -NR c COO-R e - or -NR c CONR c -R e -. Here, these groups are represented by R a Bind to.
[0138] Above R g is preferably -NR c CO-R e -It is.
[0139] Above R c are each independently a hydrogen atom, C 1-6 Alkyl group or C 6-16 It is an aryl group.
[0140] Above C 1-6 The alkyl group is preferably C 1-3 C is an alkyl group, and particularly preferably a methyl group. 1-6 The alkyl group may be straight or branched.
[0141] Above C 6-16 The aryl group is preferably C 6-10 An aryl group, more preferably a phenyl group.
[0142] In one embodiment, R c is a hydrogen atom.
[0143] In one embodiment, R c is a methyl group.
[0144] In the above formula, R e each independently represents a single bond or a divalent organic group.
[0145] In one embodiment, Re is a single bond.
[0146] In one embodiment, R e are each independently a divalent organic group.
[0147] The divalent organic group is preferably -R 43 -O x2 -R 44 -(In the formula, R 43 and R 44 each independently represents a single bond or C 1-20 is an alkylene group, and x2 is 0 or 1. 1-20 The alkylene group may be linear or branched, but is preferably linear. 1-20 The alkylene group is preferably 1-10 Alkylene group, more preferably C 1-6 Alkylene group, more preferably C 1-3 It is an alkylene group.
[0148] In the above formula (A2), x is an integer of 1 or more.
[0149] In one embodiment, x is preferably an integer of 1 or more and 100 or less, more preferably an integer of 1 or more and 10 or less, even more preferably an integer of 1 or more and 5 or less, for example, an integer of 2 or more and 10 or less, even more preferably an integer of 2 or more and 5 or less.
[0150] In a preferred embodiment, formula (A2) is represented by the following formula (A2-a): [ka] [In the formula, R b are each independently R Si , R Ac , or R c and However, R b At least one of the following is R Si and R j are each independently -CO-Rd -, -OR d - or -NR c -R d -, where the left side of these groups is R F2 Binds to R d are each independently a single bond or a divalent organic group, R F2 , R a , R c , R Ac , m3, and x are as defined above. It is.
[0151] In the above formula (A2-a), R b are each independently R Si , R Ac , or R c It is.
[0152] In the above formula (A2-a), at least one R b is R Si It is.
[0153] In a preferred embodiment, R bonded to the N atom at each end of formula (A2-a) b At least one of Si It is.
[0154] In one embodiment, R bonded to the N atom located at each end of formula (A2-a) b One of them is R Si and the other is R c It is.
[0155] In another embodiment, R bonded to the N atom located at each end of formula (A2-a) b One of them is R Si and the other is R Ac It is.
[0156] In a preferred embodiment, R Ac -CONH-X F -OCO-CR 5 =CH2.
[0157] Above R j are each independently -CO-R d -, -OR d - or -NR c -R d -. Here, these groups are R F2 Bind to.
[0158] In one embodiment, R j are each independently -CO-R d -It is.
[0159] Above R d are each independently a single bond or a divalent organic group.
[0160] In one embodiment, R d is a single bond.
[0161] In another embodiment, R d is a divalent organic group.
[0162] R d The divalent organic group in C 1-10 Alkylene group, preferably C 2-6 An alkylene group, -(CH2) z13 -O-(CH2) z14 - (wherein z13 is an integer of 0 to 6, for example, an integer of 1 to 6, and z14 is an integer of 0 to 6, for example, an integer of 1 to 6), -(CH2) z15 -Phenylene-(CH2) z16 - (wherein z15 is an integer of 0 to 6, for example, an integer of 1 to 6, and z16 is an integer of 0 to 6, for example, an integer of 1 to 6), or -(CH2) z17 -NR 10 -(CH2) z18 -(In the formula, R 10 is a hydrogen atom or C 1-6 an alkyl group, z17 is an integer of 0 to 6, and z18 is an integer of 0 to 6; These groups are, for example, fluorine atoms, C 1-6 Alkyl group, C 2-6 Alkenyl groups, and C 2-6 It may be substituted, but is preferably unsubstituted, by one or more substituents selected from alkynyl groups, which are attached to CO at the left side.
[0163] R d The divalent organic group in is preferably -(CH2) z17 -NR 10 -(CH2) z18 -(In the formula, R 10 is a hydrogen atom or C 1-6 alkyl group, z17 is an integer of 0 to 6, and z18 is an integer of 0 to 6), more preferably -NR 10 -(CH2) z18 -(In the formula, R 10 is a hydrogen atom or C 1-6 and z18 is an integer of 1 to 6.
[0164] Above C 1-10 The alkylene group may be straight-chained or branched, but is preferably straight-chained.
[0165] In a preferred embodiment, formula (A2) is represented by formula (A2-b): [ka] [In the formula, R F2 , R a , R b , R c , R d , R Ac , m3, and x are as defined above. It is.
[0166] The fluoropolyether group-containing compounds represented by the above formulas (A1) and (A2) are not particularly limited, but may be 5×10 2 ~2×10 5 Within this range, the number average molecular weight may be 2×10 3 ~1×105 , more preferably 3×10 3 ~2×10 4 From the viewpoint of refractive index and compatibility, it is preferable that the polymer has a number average molecular weight of 19 The value is measured by F-NMR.
[0167] The fluoropolyether group-containing compound represented by the above formula (A1) can be obtained by first preparing a fluoropolyether group-containing silane compound having reactive sites such as -NH-, -C(OH)-, etc., and then reacting the reactive sites with a compound having a (meth)acryl group.
[0168] In one embodiment, the fluoropolyether group-containing compound represented by the above formula (A1) is represented by the following formula: R 21 OOC-R F2 -COOR 21 (In the formula, R 21 is a hydrogen atom or a methyl group, R F2 has the same meaning as that described for formula (A1). and a compound represented by the following formula: R 24 -R 23 -NH-R 22 -SiR 1 n’ R 2 3-n’ (In the formula, R 22 is a divalent group, R 23 is a divalent group, R 24 is a reactive group such as NH R 1 , R 2 and n' are the same as those described for formula (A1). and a compound represented by the following formula: R 2 3-n’ R 1 n’ Si-R 22 -HN-R 23 -R25 -R F2 -R 25 -R 23 -NH-R 22 -SiR 1 n’ R 2 3-n’ Then, the compound represented by the following formula: R 54 -R 55 -OCOCH=CH2 (In the formula, R 54 is a reactive group such as -NCO, -COOH, COOCl, etc. R 55 is a divalent group; or R 56 -OCOCR 57 =CH2 (In the formula, R 56 is a halogen, H, or a monovalent hydrocarbon group; R 57 is a hydrogen atom or C 1-3 It is an alkyl group. It can be obtained by reacting with a compound represented by the following formula:
[0169] In one embodiment, the fluoropolyether group-containing compound represented by the above formula (A1) is represented by the following formula: FOC-R F2 -COF (In the formula, R F2 has the same meaning as that described for formula (A1). A compound represented by the formula: Br-Mg-CH2CH=CH2 By reacting with (CH2=CHCH2)2(HO)CR F2 -C(OH)(CH2CH=CH2)2 Then, the compound represented by the following formula: HSiR 1 n’ R 2 3-n’ By reacting with (R 2 3-n’R 1 n’ Si-CH2CH2CH2)2(HO)CR F2 -C(OH)(CH2CH2CH2-SiR 1 n’ R 2 3-n’ )2 Then, the compound represented by the following formula: R 34 -R 35 -OCOCH=CH2 (In the formula, R 34 is a reactive group such as -NCO, -COOH, etc. R 35 is a divalent group. It can be obtained by reacting with a compound represented by the following formula:
[0170] In one embodiment, the fluoropolyether group-containing compound represented by the above formula (A1) is represented by the following formula: HOCH2-R F2 -CHOH (In the formula, R F2 has the same meaning as that described for formula (A1). A compound represented by the formula: [ka] By reacting with [ka] Then, the compound is reacted with OCN-(CH2)3-SiR 1 n’ R 2 3-n’ (In the formula, each symbol has the same meaning as above.) By reacting with [ka] (In the formula, each symbol has the same meaning as above.) It is possible to obtain a compound represented by the following formula:
[0171] In one embodiment, the fluoropolyether group-containing compound represented by the above formula (A1) is represented by the following formula: [ka] (In the formula, each symbol has the same meaning as above.) A compound represented by the formula: CH2=CHCOOH By reacting with [ka] (In the formula, each symbol has the same meaning as above.) Then, the compound represented by the formula: OCN-(CH2)3-SiR 1 n’ R 2 3-n’ (In the formula, each symbol has the same meaning as above.) By reacting with [ka] (In the formula, each symbol has the same meaning as above.) It is possible to obtain a compound represented by the following formula:
[0172] In one embodiment, the fluoropolyether group-containing compound represented by the above formula (A2) is represented by the following formula: R 21 OOC-R F2 -COOR 21 [In the formula, R 21 is a hydrogen atom or a methyl group, R F2 has the same meaning as described for formula (A2). and a compound represented by the following formula: NH2-R 9 -(NH-R 9 ) k -NH2 [In the formula, R 9 and k are as defined in formula (A2). By reacting with R21 OOC-(R F2 -CONH-R 9 -(NH-R 9 ) k -NHCO) x -R F2 -COOR 21 [In the formula, R 21 is a hydrogen atom or a methyl group, R F2 , R 9 and k are as defined in formula (A2). Then, the resulting compound is reacted with NR 23 m H 2-m -R 22 -SiR 1 n’ R 2 3-n’ [In the formula, R 23 is C 1-6 m is 0 or 1; R 22 is a divalent group, R 1 , R 2 and n′ are as defined in formula (A2). and a compound represented by the following formula: R 2 3-n’ R 1 n’ Si-R 22 -HNOC-(R F2 -CONH-R 9 -(NH-R 9 ) k -NHCO) x -R F2 -CONH-R 22 -SiR 1 n’ R 2 3-n’ Then, the compound represented by the following formula: R 34 -R 35 -OCOCH=CH2 [In the formula, R 34 is a reactive group such as -NCO, -COOH, etc. R 35 is a divalent group. A compound represented by formula (A2) can be obtained by reacting the compound represented by formula (A3) with a compound represented by formula (A4).
[0173] In one embodiment, the fluoropolyether group-containing compound represented by the above formula (A2) is represented by the following formula: R 21 OOC-R F2 -COOR 21 [In the formula, R 21 is a hydrogen atom or a methyl group, R F2 has the same meaning as described for formula (A2). and a compound represented by the following formula: NH2-R 9 -(CH(OH)-R 9 ) k -NH2 [In the formula, R 9 and k are as defined in formula (A2). By reacting with R 21 OOC-(R F2 -CONH-R 9 -(CH(OH)-R 9 ) k -NHCO) x -R F2 -COOR 21 [In the formula, R 21 is a hydrogen atom or a methyl group, R F2 , R 9 and k are as defined in formula (A2). Then, the resulting compound is reacted with NR 23 m H 2-m -R 22 -SiR 1 n’ R 2 3-n’ [In the formula, R 23 is C 1-6 m is 0 or 1; R 22is a divalent group, R 1 , R 2 and n′ are as defined in formula (A2). and a compound represented by the following formula: R 2 3-n’ R 1 n’ Si-R 22 -HNOC-(R F2 -CONH-R 9 -(CH(OH)-R 9 ) k -NHCO) x -R F2 -CONH-R 22 -SiR 1 n’ R 2 3-n’ Then, the compound represented by the following formula: R 34 -R 35 -OCOCH=CH2 [In the formula, R 34 is a reactive group such as -NCO, -COOH, etc. R 35 is a divalent group. A compound represented by formula (A2) can be obtained by reacting the compound represented by formula (A3) with a compound represented by formula (A4).
[0174] In one embodiment, the fluoropolyether group-containing compound represented by the above formula (A2) is represented by the following formula: R 21 OOC-R F2 -COOR 21 [In the formula, R 21 is a hydrogen atom or a methyl group, R F2 has the same meaning as described for formula (A2). and a compound represented by the following formula: NH2-R 9 -(NH-R 9 ) k -NH2 [In the formula, R 9 and k are as defined in formula (A2). By reacting with R 21 OOC-(R F2 -CONH-R 9 -(NH-R 9 ) k -NHCO) x -R F2 -COOR 21 [In the formula, R 21 is a hydrogen atom or a methyl group, R F2 , R 9 and k are as defined in formula (A2). Then, the resulting compound is reacted with NH2-R 9‘ -NH2 [In the formula, R 9‘ is R 9 ] and reacting the compound represented by the following formula: R 21 OOC-(R F2 -CONH-R 9 -(NH-R 9 ) k -NHCO) x -(R F2 -CONH-R 9 '-NHCO) x’ -R F2 -COOR 21 [In the formula, R 21 is a hydrogen atom or a methyl group, R F2 , R 9 and k are as defined above with respect to formula (A2); R 9‘ is R 9 [This has the same meaning as the description regarding Then, the resulting compound is reacted with NR 23 m H 2-m -R 22 -SiR 1 n’ R 2 3-n’ [In the formula, R 23 is C 1-6m is 0 or 1; R 22 is a divalent group, R 1 , R 2 and n′ are as defined in formula (A2). and a compound represented by the following formula: R 2 3-n’ R 1 n’ Si-R 22 -HNOC-(R F2 -CONH-R 9 -(NH-R 9 ) k -NHCO) x -(R F2 -CONH-R 9 '-NHCO) x’ -R F2 -CONH-R 22 -SiR 1 n’ R 2 3-n’ Then, the compound represented by the following formula: R 34 -R 35 -OCOCH=CH2 [In the formula, R 34 is a reactive group such as -NCO, -COOH, etc. R 35 is a divalent group. A compound represented by formula (A2) can be obtained by reacting the compound represented by formula (A3) with a compound represented by formula (A4).
[0175] The reaction conditions for each step of the above reaction can be appropriately determined by those skilled in the art.
[0176] Component (B): (meth)acrylic monomer
[0177] The curable composition of the present disclosure contains a curable monomer, typically a (meth)acrylic monomer. Note that component (B) is a compound other than the compounds represented by formula (A1) and formula (A2).
[0178] In one embodiment, examples of the (meth)acrylic monomer include (a) urethane (meth)acrylate, (b) epoxy (meth)acrylate, (c) polyester (meth)acrylate, (d) polyether (meth)acrylate, (e) silicone (meth)acrylate, and (f) (meth)acrylate monomer.
[0179] Specific examples of the (meth)acrylic monomer include the following. (a) Examples of the urethane (meth)acrylate include poly[(meth)acryloyloxyalkyl]isocyanurates, such as tris(2-hydroxyethyl)isocyanurate diacrylate and tris(2-hydroxyethyl)isocyanurate triacrylate. (b) Epoxy (meth)acrylates are compounds in which a (meth)acryloyl group is added to an epoxy group, and are generally made using bisphenol A, bisphenol F, phenol novolac, or alicyclic compounds as starting materials. (c) Examples of polyhydric alcohols constituting the polyester portion of the polyester (meth)acrylate include ethylene glycol, 1,4-butanediol, 1,6-hexanediol, diethylene glycol, trimethylolpropane, dipropylene glycol, polyethylene glycol, polypropylene glycol, pentaerythritol, and dipentaerythritol. Examples of polybasic acids include phthalic acid, adipic acid, maleic acid, trimellitic acid, itaconic acid, succinic acid, terephthalic acid, and alkenylsuccinic acid. (d) Examples of polyether (meth)acrylates include polyethylene glycol di(meth)acrylate, polypropylene glycol di(meth)acrylate, and polyethylene glycol-polypropylene glycol di(meth)acrylate. (e) Silicon (meth)acrylate is a dimethylpolysiloxane having a molecular weight of 1,000 to 10,000, one or both ends of which have been modified with a (meth)acryloyl group, and examples thereof include the following compounds.
[0180]
change
[0181] (f) (meth)acrylate monomers include methyl (meth)acrylate, ethyl (meth)acrylate, n-propyl (meth)acrylate, isopropyl (meth)acrylate, n-butyl (meth)acrylate, isobutyl (meth)acrylate, sec-butyl (meth)acrylate, t-butyl (meth)acrylate, n-pentyl (meth)acrylate, 3-methylbutyl (meth)acrylate, n-hexyl (meth)acrylate, 2-ethyl-n-hexyl (meth)acrylate, n-octyl (meth)acrylate, 2-methyl-n ... Ctyl (meth)acrylate, cyclohexyl (meth)acrylate, isobornyl (meth)acrylate, benzyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 4-hydroxybutyl (meth)acrylate, 5-hydroxypentyl (meth)acrylate, 6-hydroxyhexyl (meth)acrylate, 4-hydroxycyclohexyl (meth)acrylate, neopentyl glycol Mono(meth)acrylate, 3-chloro-2-hydroxypropyl(meth)acrylate, (1,1-dimethyl-3-oxobutyl)(meth)acrylate, 2-acetoacetoxyethyl(meth)acrylate, 2-methoxyethyl(meth)acrylate, 2-ethoxyethyl(meth)acrylate, neopentyl glycol mono(meth)acrylate, 3-chloro-2-hydroxypropyl(meth)acrylate, glycerin mono(meth)acrylate, ethylene glycol di(meth)acrylate, propylene glycol Examples include ethylene glycol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, 1,9-nonanediol di(meth)acrylate, 1,10-decanediol di(meth)acrylate, trimethylolpropane tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, 2-isocyanateethyl (meth)acrylate, 1,1-(bis(meth)acryloyloxymethyl)ethyl isocyanate, glycidyl (meth)acrylate, and (meth)acrylic acid.
[0182] In one embodiment, the (meth)acrylic monomer includes a fluorine-containing (meth)acrylic monomer.
[0183] In one embodiment, the fluorine-containing (meth)acrylic monomer is represented by the following formula (M): (CH2=CR 71 -COO-) m1 -X 7 -R F72 -X 7 -(OCO-CR 71 =CH2) m1 [In formula: R F72 is -Rf 2 p -R F -O q - and Rf 2 C may be substituted with one or more fluorine atoms. 1-6 is an alkylene group, R F are each independently a divalent fluoropolyether group, p is 0 or 1; Each q is independently 0 or 1; R 71 are each independently a hydrogen atom or C 1-6 is an alkyl group, X 7 are each independently a divalent to pentavalent organic group, Each m1 is independently an integer of 1 to 4. The compound may be represented by the formula:
[0184] Above Rf 2 , R F , p, and q are the same as defined in formulae (A1) and (A2) above.
[0185] In one embodiment, R 71 is a hydrogen atom.
[0186] In another embodiment, R 71 are each independently1-6 It is an alkyl group.
[0187] Above C 1-6 The alkyl group is preferably C 1-3 It is preferably an alkyl group, more preferably a methyl group or an ethyl group, and even more preferably a methyl group. 1-6 The alkyl group may be straight or branched.
[0188] X 7 are each independently a divalent to pentavalent organic group.
[0189] In one embodiment, X 7 is a divalent organic group.
[0190] In another embodiment, X 7 is a trivalent to pentavalent organic group.
[0191] In a preferred embodiment, X 7 are each independently a single bond or a group represented by the following formula: -(R 55 ) p7 -(R 56 ) q7 - [In formula: R 55 is a single bond, C 1-20 an alkylene group, or an o-, m- or p-phenylene group; R 56 each independently represents -O-, -S-, o-, m- or p-phenylene group, -COO-, -OCO-, -CONR 57 -, -NR 57 CO-, -O-CONR 57 -, -NR 57 CO-O- and -NR 57 - is a group selected from the group consisting of R 57 are each independently a hydrogen atom, a phenyl group, or C 1-6 is an alkyl group, p7 is an integer from 0 to 6, q7 is an integer from 0 to 6, Here, at least one of p7 and q7 is 1 or more, and the order of the repeating units enclosed in parentheses with p7 or q7 is arbitrary. It is possible for X to be a divalent organic group represented by the following formula: 7 In the case of two or more homogeneous R 56 do not combine consecutively.
[0192] In one embodiment, X 7 is a single bond.
[0193] In another embodiment, X 7 is -(R 55 ) p7 -(R 56 ) q7 - is a group represented by the formula:
[0194] R 55 is preferably C 1-20 An alkylene group, or an o-, m- or p-phenylene group, more preferably C 1-20 It may be an alkylene group. 1-20 The alkylene group is preferably 1-10 Alkylene group, more preferably C 1-6 It may be an alkylene group. Such an alkylene group may be a straight chain or a branched chain.
[0195] R 56 is preferably -O-, -COO-, -OCO-, -CONR 57 -, -NR 57 CO-, -O-CONR 57 -, -NR 57 CO-O- or -NR 57 -, more preferably -COO-, -OCO-, -CONR 57 -, -NR 57 CO-, -O-CONR 57 - or -NR 57 CO-O-, more preferably -CONR 57 --It could be.
[0196] R 57 is preferably a hydrogen atom or C 1-6It is an alkyl group.
[0197] In one embodiment, R 57 is a hydrogen atom.
[0198] In another embodiment, R 57 is C 1-6 Alkyl groups, preferably C 1-3 It is preferably an alkyl group, more preferably a methyl group. The alkyl group may be linear or branched.
[0199] In one embodiment, p7 is 0.
[0200] In another embodiment, p7 is an integer from 1 to 6, such as an integer from 1 to 3, or 1.
[0201] In one embodiment, q7 is 0.
[0202] In another embodiment, q7 is an integer from 1 to 6, such as an integer from 1 to 3, or 1.
[0203] In a preferred embodiment, the fluorine-containing (meth)acrylic monomer may be 1,6-bis(acryloyloxy)-2,2,3,3,4,4,5,5-octafluorohexane.
[0204] In one embodiment, the fluorine-containing (meth)acrylic monomer is, for example, 2,2,2-trifluoroethyl (meth)acrylate, 1,1,1,3,3,3-hexafluoroisopropyl (meth)acrylate, 2,2,3,3,4,4,4-heptafluorobutyl (meth)acrylate, 2,2,3,4,4,4-hexafluorobutyl (meth)acrylate, 1H,1H,2H,2H-nonafluorohexyl (meth)acrylate, 1H,1H,5H-octafluoropentyl (meth)acrylate, pentafluorophenyl (meth)acrylate, 2, Examples of the fluoroalkyl groups include 2,3,3,3-pentafluoropropyl (meth)acrylate, 2,2,3,3-tetrafluoropropyl (meth)acrylate, 1H,1H,2H,2H-tridecafluoro-n-octyl (meth)acrylate, 1H,1H,2H,2H-heptadecafluorodecyl (meth)acrylate, 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptyl (meth)acrylate, 1,6-bis(acryloyloxy)-2,2,3,3,4,4,5,5-octafluorohexane, and methyl 2-fluoroacrylate.
[0205] In a preferred embodiment, the fluorine-containing (meth)acrylic monomer can be 2,2,3,3,4,4,4-heptafluorobutyl (meth)acrylate.
[0206] Component (C): Radical polymerization initiator
[0207] The radical polymerization initiator may preferably be a radical photopolymerization initiator. Examples of the radical photopolymerization initiator include diketones such as benzyl and diacetyl, acyloins such as benzoin, acyloin ethers such as benzoin methyl ether, benzoin ethyl ether, and benzoin isopropyl ether, thioxanthones such as thioxanthones, 2,4-diethylthioxanthones, and thioxanthones-4-sulfonic acid, benzophenones such as 4,4'-bis(dimethylamino)benzophenone, and 4,4'-bis(diethylamino)benzophenone, acetophenone, 2-(4-toluenesulfonyloxy)-2-phenylacetophenone, p-dimethylaminoacetophenone, 2,2'-dimethoxy-2-phenylacetophenone, and p-methoxyacetophenone. acetophenones such as cetophenone, 2-methyl[4-(methylthio)phenyl]-2-morpholino-1-propanone, 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butan-1-one; quinones such as anthraquinone and 1,4-naphthoquinone; aminobenzoic acids such as ethyl 2-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate, (n-butoxy)ethyl 4-dimethylaminobenzoate, isoamyl 4-dimethylaminobenzoate, and 2-ethylhexyl 4-dimethylaminobenzoate; halogen compounds such as phenacyl chloride and trihalomethylphenyl sulfone; acylphosphine oxides; and peroxides such as di-t-butyl peroxide.
[0208] In a preferred embodiment, the radical polymerization initiator is selected from the group consisting of benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, thioxanthone, 2,4-diethylthioxanthone, thioxanthone-4-sulfonic acid, benzophenone, 4,4'-bis(dimethylamino)benzophenone, 4,4'-bis(diethylamino)benzophenone, acetophenone, 2-(4-toluenesulfonyloxy)-2-phenylacetophenone, p-dimethylaminoacetophenone, and 2,2'-dimethoxy-2-phenyl Acetophenone, p-methoxyacetophenone, 2-methyl[4-(methylthio)phenyl]-2-morpholino-1-propanone, 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butan-1-one, anthraquinone, 1,4-naphthoquinone, ethyl 2-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate, (n-butoxy)ethyl 4-dimethylaminobenzoate, isoamyl 4-dimethylaminobenzoate, 2-ethylhexyl 4-dimethylaminobenzoate, phenacyl chloride, trihalomethylphenanthracene, Nilsulfone, acylphosphine oxide, or di-t-butyl peroxide, methylbenzoyl formate, 1-hydroxy-cyclohexyl-phenyl-ketone, 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propan-1-one, 2-hydroxy-1-{4-[4-(2-hydroxy-2-methyl-propionyl)-benzyl]phenyl}-2-methyl-propan-1-one, 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one, 2-benzyl-2- Dimethylamino-1-(4-morpholinophenyl)-1-butanone, 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(4-morpholinyl)phenyl]-1-butanone, bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide, bis(η5-2,4-cyclopentadiene-1-yl)-bis(2,6-difluoro-3-(1H-pyrrol-1-yl)-phenyl)titanium, 1,2-octanedione, 1-[4-(phenylthio)-, 2-(O-benzoyloxime)], ethanone,1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]-, 1-(0-acetyloxime), 2-hydroxy-2-methyl-1-phenyl-propan-1-one, 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide, t-butyl hydroperoxide, cumene hydroperoxide, diisopropylbenzene hydroperoxide, permentha hydroperoxide, or t-methylbutyl hydroperoxide.
[0209] Examples of commercially available radical photopolymerization initiators include the following. OMNIRAD 651: 2,2-dimethoxy-1,2-diphenylethan-1-one, OMNIRAD 184: 1-Hydroxy-cyclohexyl-phenyl-ketone, OMNIRAD 2959: 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propan-1-one, OMNIRAD 127: 2-hydroxy-1-{4-[4-(2-hydroxy-2-methyl-propionyl)-benzyl]phenyl}-2-methyl-propan-1-one, OMNIRAD 907: 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one, OMNIRAD 369: 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butanone-1, OMNIRAD 379: 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(4-morpholinyl)phenyl]-1-butanone, OMNIRAD 819: Bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide, OMNIRAD 784: bis(η5-2,4-cyclopentadien-1-yl)-bis(2,6-difluoro-3-(1H-pyrrol-1-yl)-phenyl)titanium; OMNIRAD OXE 01: 1,2-Octanedione, 1-[4-(phenylthio)-, 2-(O-benzoyloxime)], OMNIRAD OXE 02: Ethanone, 1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]-, 1-(0-acetyloxime), OMNIRAD261, OMNIRAD369, OMNIRAD500, DAROCUR 1173: 2-hydroxy-2-methyl-1-phenyl-propan-1-one, DAROCUR TPO: 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide, DAROCUR1116, DAROCUR2959, DAROCUR1664, DAROCUR4043, OMNIRAD 754 Oxyphenylacetic acid: Mixture of 2-[2-oxo-2-phenylacetoxyethoxy]ethyl ester and oxyphenylacetic acid, 2-(2-hydroxyethoxy)ethyl ester; OMNIRAD 500: A mixture of OMNIRAD 184 and benzophenone (1 :1), OMNIRAD 1300: a mixture of OMNIRAD 369 and OMNIRAD 651 (3:7), OMNIRAD 1800: a mixture of CGI403 and OMNIRAD 184 (1:3), OMNIRAD 1870: A mixture of CGI403 and OMNIRAD 184 (7:3), DAROCUR 4265: A mixture of DAROCUR TPO and DAROCUR 1173 (1:1). OMNIRAD is manufactured by BASF, and DAROCUR is manufactured by Merck Japan.
[0210] The content of component (A) relative to the total amount of components (A) and (B) may be preferably 60 mass% or more, more preferably 70 mass% or more, and even more preferably 80 mass% or more, for example 85 mass% or more, 90 mass% or more, or 95 mass% or more.
[0211] The content of component (A) may be preferably 99% by mass or less, more preferably 95% by mass or less, for example 90% by mass or less, 85% by mass or less, or 80% by mass or less, based on the total amount of components (A) and (B).
[0212] The content of component (A) relative to the total amount of component (A) and component (B) can be, for example, 60 to 99 mass%, preferably 60 to 95 mass%, more preferably 60 to 90 mass%, and even more preferably 60 to 80 mass%, for example, 70 to 90 mass%, or 80 to 90 mass%.
[0213] The curable composition of the present disclosure contains component (A) and component (B), particularly in the above-mentioned ratio, and thus gives a cured product that exhibits excellent adhesion, particularly excellent adhesion to glass, quartz, etc. Furthermore, the resulting cured product has a relatively low refractive index, particularly a refractive index lower than that of glass or quartz, and therefore may be useful as a cladding material in an optical waveguide.
[0214] The component (C) is contained in an amount of preferably 0.1 to 20 parts by mass, more preferably 1 to 10 parts by mass, and further preferably 1 to 5 parts by mass, relative to 100 parts by mass in total of the components (A) and (B).
[0215] The curable compositions of the present disclosure may include a solvent.
[0216] The solvent may be preferably aliphatic hydrocarbons, aromatic hydrocarbons, esters, ketones, glycol ethers, alcohols, glycols, cyclic ethers, amides, ether alcohols, perfluoroaliphatic hydrocarbons having 5 to 12 carbon atoms, polyfluoroaromatic hydrocarbons, polyfluoroaliphatic hydrocarbons, hydrofluorocarbons, hydrochlorofluorocarbons, or hydrofluoroethers. The solvent may be a mixed solvent of two or more of these.
[0217] In a preferred embodiment, the solvent is an alcohol, a hydrofluoroether, or a mixed solvent of two or more of these.
[0218] Examples of the aliphatic hydrocarbons include hexane, cyclohexane, heptane, octane, nonane, decane, undecane, dodecane, mineral spirits, and the like.
[0219] Examples of the aromatic hydrocarbons include benzene, toluene, xylene, naphthalene, and solvent naphtha.
[0220] Examples of the esters include methyl acetate, ethyl acetate, propyl acetate, n-butyl acetate, isopropyl acetate, isobutyl acetate, cellosolve acetate, propylene glycol methyl ether acetate, carbitol acetate, diethyl oxalate, ethyl pyruvate, ethyl 2-hydroxybutyrate, ethyl acetoacetate, amyl acetate, methyl lactate, ethyl lactate, methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 2-hydroxyisobutyrate, and ethyl 2-hydroxyisobutyrate.
[0221] Examples of the ketones include acetone, methyl ethyl ketone, methyl isobutyl ketone, 2-hexanone, cyclohexanone, methylamino ketone, and 2-heptanone.
[0222] Examples of the glycol ethers include ethyl cellosolve, methyl cellosolve, methyl cellosolve acetate, ethyl cellosolve acetate, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monobutyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, propylene glycol monobutyl ether acetate, dipropylene glycol dimethyl ether, and diethylene glycol monoethyl ether acetate.
[0223] Examples of the alcohols include methanol, ethanol, iso-propanol, n-butanol, isobutanol, tert-butanol, sec-butanol, 3-pentanol, octyl alcohol, 3-methyl-3-methoxybutanol, tert-amyl alcohol, etc. The alcohols are preferably methanol, ethanol, or iso-propanol.
[0224] Examples of the glycols include ethylene glycol and propylene glycol.
[0225] Examples of the cyclic ethers include tetrahydrofuran, tetrahydropyran, and dioxane.
[0226] Examples of the amides include N,N-dimethylformamide and N,N-dimethylacetamide.
[0227] Examples of the ether alcohols include methyl cellosolve, cellosolve, isopropyl cellosolve, butyl cellosolve, and diethylene glycol monomethyl ether.
[0228] Examples of the perfluoroaliphatic hydrocarbon having 5 to 12 carbon atoms include perfluorohexane, perfluoromethylcyclohexane, and perfluoro-1,3-dimethylcyclohexane.
[0229] The polyfluoroaromatic hydrocarbons include bis(trifluoromethyl)benzene and the like.
[0230] The polyfluoroaliphatic hydrocarbons include C6F 13 Examples of such an alkoxysilane include CH2CH3 (for example, Asahiklin (registered trademark) AC-6000 manufactured by Asahi Glass Co., Ltd.), 1,1,2,2,3,3,4-heptafluorocyclopentane (for example, Zeorora (registered trademark) H manufactured by Zeon Corporation), and the like.
[0231] Hydrofluorocarbons (HFCs) include 1,1,1,3,3-pentafluorobutane (HFC-365mfc) and the like.
[0232] Examples of hydrochlorofluorocarbons (HCFCs) include 1,1,2-trichloro-1,2,2-trifluoroethane, 1,2-dichloro-1,1,2,2-tetrafluoroethane, and 1,1-dichloro-1,2,2,3,3-pentafluoropropane (HCFC225) (for example, Asahiklin (registered trademark) AK225).
[0233] Examples of the hydrofluoroether (HFE) include alkyl perfluoroalkyl ethers (perfluoroalkyl groups and alkyl groups may be linear or branched) such as perfluoropropyl methyl ether (C3F7OCH3) (e.g., Novec (trademark) 7000 manufactured by Sumitomo 3M Limited), perfluorobutyl methyl ether (C4F9OCH3) (e.g., Novec (trademark) 7100 manufactured by Sumitomo 3M Limited), perfluorobutyl ethyl ether (C4F9OC2H5) (e.g., Novec (trademark) 7200 manufactured by Sumitomo 3M Limited), and perfluorohexyl methyl ether (C2F5CF(OCH3)C3F7) (e.g., Novec (trademark) 7300 manufactured by Sumitomo 3M Limited), CF3CH2OCF2CHF2 (e.g., Asahiklin (registered trademark) AE-3000 manufactured by Asahi Glass Co., Ltd.), and the like.
[0234] In a preferred embodiment, the solvent is methanol, ethanol, iso-propanol, perfluoropropyl methyl ether, perfluorobutyl methyl ether, perfluorobutyl ethyl ether, perfluorohexyl methyl ether, or CF3CH2OCF2CHF2, or a mixture of two or more of these.
[0235] The content of the solvent may be preferably 20 to 90% by mass, and more preferably 40 to 90% by mass, based on the total amount of components (A) to (C).
[0236] The curable composition of the present disclosure may contain a (non-reactive) fluoropolyether compound that can be understood as a fluorine-containing oil, preferably a perfluoro(poly)ether compound (hereinafter collectively referred to as a "fluorine-containing oil"), a (non-reactive) silicone compound that can be understood as a silicone oil (hereinafter referred to as a "silicone oil"), a catalyst, an alcohol, a surfactant, a polymerization inhibitor, a sensitizer, a UV fluorescent agent, and the like.
[0237] The fluorine-containing oil is not particularly limited, but examples thereof include compounds represented by the following general formula (3) (perfluoro(poly)ether compounds). Rf 5 -(OC4F8) a’ -(OC3F6) b’ -(OC2F4) c’ -(OCF2) d’ -Rf 6 (3) In the formula, Rf 5 is an alkyl group having 1 to 16 carbon atoms which may be substituted with one or more fluorine atoms (preferably, 1-16 Rf represents a perfluoroalkyl group; 6 is an alkyl group having 1 to 16 carbon atoms which may be substituted with one or more fluorine atoms (preferably, 1-16 perfluoroalkyl group), a fluorine atom or a hydrogen atom; Rf 5 and Rf 6 More preferably, each independently represents C 1-3 It is a perfluoroalkyl group. a', b', c' and d' respectively represent the number of four types of repeating units of perfluoro(poly)ether constituting the main skeleton of the polymer, and are each independently an integer of 0 to 300, and the sum of a', b', c' and d' is at least 1, preferably 1 to 300, and more preferably 20 to 300. The order of the repeating units enclosed in parentheses with the subscript a', b', c' or d' is arbitrary in the formula. These repeating units may be linear or branched, or may contain a ring structure. For example, -(OC4F8)- may be any of -(OCF2CF2CF2CF2)-, -(OCF(CF3)CF2CF2)-, -(OCF2CF(CF3)CF2)-, -(OCF2CF2CF(CF3))-, -(OC(CF3)2CF2)-, -(OCF2C(CF3)2)-, -(OCF(CF3)CF(CF3))-, -(OCF(C2F5)CF2)-, and (OCF2CF(C2F5))-, but is preferably -(OCF2CF2CF2CF2)-. -(OC3F6)- may be any of -(OCF2CF2CF2)-, -(OCF(CF3)CF2)-, and (OCF2CF(CF3))-, but is preferably -(OCF2CF2CF2)-. -(OC2F4)- may be either -(OCF2CF2)- or (OCF(CF3))-, but is preferably -(OCF2CF2)-.
[0238] The ring structure may be the following three- or four-membered ring: [ka] [In the formula, * indicates the bond position.] It can be
[0239] For example, (OC4F8) [ka] [In the formula, * indicates the bond position.] It could be.
[0240] Examples of the perfluoro(poly)ether compound represented by the above general formula (3) include compounds represented by the following general formulas (3a) and (3b) (which may be one type or a mixture of two or more types). Rf 5 -(OCF2CF2CF2) b” -Rf 6 (3a) Rf 5 -(OCF2CF2CF2CF2) a” -(OCF2CF2CF2) b” -(OCF2CF2) c” -(OCF2) d” -Rf 6 (3b) In these formulas, Rf 5 and Rf 6 is as defined above; in formula (3a), b" is an integer of 1 or more and 100 or less; in formula (3b), a" and b" are each independently an integer of 0 or more and 30 or less, and c" and d" are each independently an integer of 1 or more and 300 or less. The order of occurrence of each repeating unit enclosed in parentheses with the subscripts a", b", c", and d" is arbitrary in the formula.
[0241] From another perspective, the fluorine-containing oil is represented by the general formula Rf 3 -F(where Rf 3 is C 5-16 It may be a compound represented by the formula: embedded image which is a perfluoroalkyl group. It may also be a chlorotrifluoroethylene oligomer.
[0242] The above-mentioned fluorine-containing oil may have an average molecular weight of 500 to 10000. The molecular weight of the fluorine-containing oil can be measured using GPC.
[0243] The fluorinated oil may be contained in an amount of, for example, 0 to 50 mass%, preferably 0 to 30 mass%, more preferably 0 to 5 mass% relative to the curable composition of the present disclosure. In one embodiment, the curable composition of the present disclosure is substantially free of fluorinated oil. "Substantially free of fluorinated oil" means that the composition does not contain any fluorinated oil at all, or may contain a very small amount of fluorinated oil.
[0244] The silicone oil may be, for example, a linear or cyclic silicone oil having 2,000 or less siloxane bonds. The linear silicone oil may be a so-called straight silicone oil or a modified silicone oil. The straight silicone oil may be, for example, dimethyl silicone oil, methylphenyl silicone oil, or methylhydrogen silicone oil. The modified silicone oil may be, for example, a straight silicone oil modified with alkyl, aralkyl, polyether, higher fatty acid ester, fluoroalkyl, amino, epoxy, carboxyl, or alcohol. The cyclic silicone oil may be, for example, cyclic dimethylsiloxane oil.
[0245] In the curable composition of the present disclosure, such silicone oil may be contained in an amount of, for example, 0 to 300 parts by mass, preferably 50 to 200 parts by mass, relative to 100 parts by mass in total of the fluoropolyether group-containing compound and fluoropolyether group-containing silane compound of the present disclosure (when two or more types are used, the total of these, the same applies below).
[0246] The catalyst is not particularly limited, but examples thereof include acids (e.g., acetic acid, trifluoroacetic acid, etc.), bases (e.g., ammonia, triethylamine, diethylamine, etc.), transition metals (e.g., Ti, Ni, Sn, etc.), metal complexes such as tin-based catalysts, titanium-based catalysts, zirconia-based catalysts, bismuth-based catalysts, and organic amine-based catalysts.
[0247] An example of the tin catalyst is di-n-butyltin(IV) dilaurate. Examples of the titanium catalyst include titanium diisopropoxybis(ethylacetoacetate), titanium tetra-n-butoxide, titanium tetra-2-ethylhexoxide, and titanium tetraacetylacetonate. Examples of the zirconia catalyst include zirconium tetraacetylacetonate, zirconium tetra-n-butoxide, and zirconium dibutoxybis(ethylacetoacetate). The bismuth-based catalyst includes bismuth tris(2-ethylhexanoate). An example of the organic amine catalyst is diazabicycloundecene.
[0248] The catalyst may be added to the curable composition immediately prior to use.
[0249] The catalyst may additionally be added to the curable composition immediately prior to use, depending on the method of use.
[0250] The catalyst may be contained in an amount of preferably 0.1 to 20 parts by mass, more preferably 0.2 to 10 parts by mass, and even more preferably 0.5 to 5 parts by mass, relative to 100 parts by mass in total of the components (A) and (B).
[0251] Examples of the alcohols include alcohols having 1 to 6 carbon atoms which may be substituted with one or more fluorine atoms, such as methanol, ethanol, iso-propanol, tert-butanol, CF3CH2OH, CF3CF2CH2OH, and (CF3)2CHOH. By adding these alcohols to the curable composition, the stability of the curable composition is improved, and the compatibility of the perfluoropolyether group-containing compound and the fluoropolyether group-containing silane compound with the solvent is improved.
[0252] The alcohol is preferably methanol, ethanol, 2,2,3,3,3-pentafluoro-1-propanol or 2,2,2-trifluoroethanol.
[0253] In addition to the components described above, the curable composition of the present disclosure may contain trace amounts of impurities such as Pt, Rh, Ru, 1,3-divinyltetramethyldisiloxane, triphenylphosphine, NaCl, KCl, and silane condensates.
[0254] The viscosity of the curable composition of the present disclosure may be preferably 5000 mPa·s or less, more preferably 3000 mPa·s or less, and even more preferably 2000 mPa·s or less. By reducing the viscosity of the curable composition, it becomes possible to apply the curable composition to a location with a finer shape. In addition, the viscosity of the curable composition of the present disclosure may be preferably 100 mPa·s or more, more preferably 500 mPa·s or more, and even more preferably 1000 mPa·s or more. By increasing the viscosity of the curable composition, it becomes easier to form a thick film and to control the wetting and spreading.
[0255] In one embodiment, the viscosity of the curable composition of the present disclosure may be preferably 100 to 5000 mPa·s, more preferably 500 to 3000 mPa·s, and even more preferably 1000 to 2000 mPa·s.
[0256] (Application) The cured product of the curable composition of the present disclosure can be used, for example, as a clad material, particularly as a clad material for an optical waveguide. The cured product of the curable composition of the present disclosure has a low refractive index and high adhesion after curing, and is therefore particularly suitable for the above applications.
[0257] The cured product of the curable composition of the present disclosure may also be used as a potting material, a sealing material, etc. The cured product of the curable composition of the present disclosure may be used, for example, by filling a gap in an electronic component (for example, a bonding portion between a housing and a printed circuit board, or a gap between a resin-molded metal terminal and a molding resin, etc.) and curing it.
[0258] The curable composition of the present disclosure can also be used as a hard coating agent since it can form a layer having good adhesion and alcohol resistance to various substrates.
[0259] The curable composition of the present disclosure can form a cured product having good adhesion to metal or plastic substrates, and therefore can be useful as an adhesive or sealant for applications around electric and electronic components and in-vehicle components. The curable composition of the present disclosure has a good elastic modulus even at low temperatures, and therefore can be useful in automobile components (e.g., sealants, specifically, gaskets), and the like, particularly automobile components that can be used in cold regions (e.g., −50° C. or lower). Furthermore, the cured product of the curable composition of the present disclosure can also be useful as a resin mold (replica mold) for nanoimprinting.
[0260] The cured product of the curable composition of the present disclosure has good chemical resistance, acid resistance, and base resistance, and can be used in chemical plants, semiconductor manufacturing equipment, and the like.
[0261] The present disclosure provides a cured product obtained from the curable composition of the present disclosure. The curable composition of the present disclosure has excellent curability and coatability, and therefore can be used as a cured product for various applications.
[0262] The present disclosure includes an article comprising a substrate and a cured layer formed on the substrate by curing the curable composition of the present disclosure.
[0263] Substrates that can be used in the present disclosure may be made of any suitable material, such as glass, resin (which may be a natural or synthetic resin, for example, a general plastic material), OCA (Optical Clear Adhesive), polarizing plate metal, ceramics, semiconductors (silicon, germanium, etc.), electronic devices, fibers (woven fabrics, nonwoven fabrics, etc.), fur, leather, wood, ceramics, stone, etc., building materials, etc., sanitary products, etc.
[0264] In a preferred embodiment, the substrate may be glass, a resin, a polarizing plate, an OCA (Optical Clear Adhesive), or a metal.
[0265] As the above glass, sapphire glass, soda-lime glass, alkali aluminosilicate glass, borosilicate glass, alkali-free glass, crystal glass, and quartz glass are preferred, and chemically strengthened soda-lime glass, chemically strengthened alkali aluminosilicate glass, and chemically bonded borosilicate glass are particularly preferred.
[0266] The shape of the substrate is not particularly limited and may be, for example, a plate, a film, or other form. The surface region of the substrate on which the cured layer is to be formed may be at least a part of the substrate surface, and may be appropriately determined depending on the application and specific specifications of the product to be manufactured.
[0267] The article of the present disclosure can be produced by forming a layer of the curable composition of the present disclosure described above on the surface of the substrate, and optionally post-treating the layer, thereby forming a layer from the curable composition of the present disclosure.
[0268] The layer formation of the curable composition of the present disclosure can be carried out by applying the curable composition to the surface of a substrate so as to cover the surface. The coating method is not particularly limited. For example, a wet coating method and a dry coating method can be used.
[0269] Examples of wet coating methods include dip coating, bar coating, spin coating, flow coating, spray coating, roll coating, gravure coating, needle dispensing, jet dispensing and similar methods. The wet coating method is preferably bar coating, spin coating, flow coating, roll coating, needle dispensing or jet dispensing.
[0270] In a preferred embodiment, the article of the present disclosure may be an electric / electronic part, an in-vehicle part, an automobile component (for example, a sealing material, specifically, a gasket), a chemical plant, a semiconductor manufacturing device, or the like.
[0271] The article of the present disclosure may also be a medical device or medical material.
[0272] The thickness of the layer is not particularly limited, but may be, for example, 1 μm or more, 10 μm or more, or 100 μm or more. The thickness of the layer is not particularly limited, but may be, for example, 1000 μm or less, 500 μm or less, or 100 μm or less.
[0273] The curable composition, the cured product, the article, and the like of the present disclosure have been described in detail above. However, these of the present disclosure are not limited to the above examples. EXAMPLES
[0274] The compounds of the present disclosure will be described below in the Examples, but the present disclosure is not limited to the following Examples. In the Examples, the order of the repeating units constituting the fluoropolyether is arbitrary, and the chemical formula shown below shows the average composition.
[0275] Component (A): Fluoropolyether group-containing compound Compound (A-1): (CH3O)3SiCH2CH2CH2N(X)CH2CH2NHCOCF2O(CF2CF2O) 12 (CF2O) 12 CF2CONHCH2CH2N(X)CH2CH2CH2Si(OCH3)3 X=-CONHCH2CH2OCOCH=CH2
[0276] Compound (A-2): (CH3O)3SiCH2CH2CH2N(X)CH2CH2NHCOCF2O(CF2CF2O) 12 (CF2O) 12 CF2CONHCH2CH2NHCOCF2O(CF2CF2O) 12 (CF2O) 12 CF2CONHCH2CH2N(X)CH2CH2CH2Si(OCH3)3 X=-CONHCH2CH2OCOCH=CH2
[0277] Component (B): (meth)acrylic monomer (B-1) Trimethylolpropane triacrylate (B-2) 1,6-bis(acryloyloxy)-2,2,3,3,4,4,5,5-octafluorohexane
[0278] Component (C): Radical polymerization initiator (C-1) Omnirad MBF (Methyl Benzoyl Formate) (C-2) Cumene hydroperoxide
[0279] Examples 1 to 6 Curable compositions were prepared by mixing the components (A) to (C) in the ratios (weight ratios) shown in the following Table 1. The obtained curable compositions were evaluated as follows.
[0280] Comparative Example 1 Curable compositions were prepared and evaluated in the same manner as in Example 1, except that the components (A) to (C) were mixed in the ratios (weight ratios) shown in the table below.
[0281] Comparative Example 2 The following fluoropolyether group-containing compound (A-3) was synthesized according to the method described in JP-A-7-188561. A curable composition was prepared and evaluated in the same manner as in Comparative Example 1, except that the following compound (A-3) was used instead of the compound (A-1).
[0282] Compound (A-3): X n (CH3O) 3-n SiCH2CH2CH2NHCOCF2O(CF2CF2O) 12 (CF2O) 12 CF2CONHCH2CH2CH2Si(OCH3) 3-n X n X=(OSiCH3)2CH2OCOCH=CH2) n n=1.9
[0283] Comparative Example 3 The following fluoropolyether group-containing compound (A-4) was synthesized according to the method described in JP-A-10-197731. A curable composition was prepared and evaluated in the same manner as in Comparative Example 1, except that the following compound (A-4) was used instead of the compound (A-1).
[0284] Compound (A-4): A mixture of the following three types [ka] [ka] [ka]
[0285] <evaluation> The curable compositions obtained above were evaluated for compatibility, refractive index, and adhesion as follows.
[0286] Compatibility evaluation When mixed in the ratio (weight ratio) shown in the table below, the compatibility of the composition components was evaluated visually according to the following criteria. 〇: Transparent solution ×: Cloudy
[0287] Refractive index measurement The refractive index was measured by placing a small amount of the sample on the prism of an Abbe refractometer and observing the bright and dark areas produced by the light emitted from the prism using a sodium light source D line (589 nm) at room temperature.
[0288] Adhesion Test A film with a thickness of 200 μm was formed on the glass using an applicator, and the accumulated light quantity of 1000 mJ / cm was emitted from a high-pressure mercury lamp. 2The cured product was then left to stand for 3 days in a 23°C / 50% RH environment to cure. 25 grid-shaped cuts were made in the cured product thus obtained with a cutter at 2 mm intervals, and cellophane tape was applied on top of the cuts and slowly peeled off. The number of pieces of cured product remaining on the glass after peeling was determined, and the adhesion to the glass was evaluated according to the following criteria. 5: No peeling 4: More than 20 squares remain on the glass 3:15 or more squares remain on the glass 2: More than 10 squares remain on the glass Less than 1:9 squares remaining
[0289] [Table 1] [Industrial Applicability]
[0290] The curable composition of the present disclosure can be suitably used to form a cured layer on a wide variety of substrates.
Claims
1. Component (A): a fluoropolyether group-containing compound, Component (B): (meth)acrylic monomer, and Component (C): Radical polymerization initiator Including, The fluoropolyether group-containing compound is represented by the following formula (A1) or (A2): 【Chemistry 1】 [In the formula: R F2 Each independently represents -Rf 2 p -R F -O q - and Rf 2 C optionally substituted with one or more fluorine atoms 1-6 is an alkylene group, R F are each independently a divalent fluoropolyether group; p is 0 or 1; Each q is independently 0 or 1; X A are each independently a single bond or a divalent organic group, X B are each independently a (m+1)-valent group, In each formula, at least one X B is a (m+1)-valent group containing a hydrolyzable silyl group, R Ac are each independently -X D -X E (-X F -OCO-CR 5 =CH 2 ) m’ and X D is a single bond or a divalent group, X E represents a single bond or a group having a valence of (m'+1), X F are each independently a single bond or a divalent group, R 5 is a hydrogen atom, a halogen atom, or a monovalent organic group having 1 to 8 carbon atoms, m' is an integer from 1 to 10, Each m is independently an integer from 0 to 10; R a each independently represents an organic group having a valence of (m+2), m3 is an integer from 0 to 4, However, at least one of m and m3 is 1 or more, R g are each independently -NR c C.O.R. e --, --NR c COO-R e - or -NR c C.O.N.R. c -R e -, where the left side of these groups is R a Binds to R c are each independently a hydrogen atom, C 1-6 Alkyl group, or C 6-16 is an aryl group, R e are each independently a single bond or a divalent organic group, x is an integer of 1 or more. A curable composition comprising at least one compound represented by the following formula:
2. The curable composition according to claim 1 , wherein the content of the component (A) is 60 mass % or more based on the total amount of the components (A) and (B).
3. The curable composition according to claim 1 , wherein the content of the component (A) is 80 mass % or more based on the total amount of the components (A) and (B).
4. R F each independently represents the formula: -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 R Fa 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - [In the formula, R Fa are each independently a hydrogen atom, a fluorine atom or a chlorine atom, a, b, c, d, e, and f each independently represent an integer of 0 to 200, the sum of a, b, c, d, e, and f is 1 or more, and the order of the repeating units enclosed in parentheses with a, b, c, d, e, or f is arbitrary in the formula, provided that all R Fa is a hydrogen atom or a chlorine atom, at least one of a, b, c, e and f is 1 or more. The curable composition according to claim 1 , wherein the group is represented by the formula:
5. R F each independently represents the following formula (f1), (f2), (f3), (f4), (f5), or (f6): -(OC 3 F 6 ) d -(OC 2 F 4 ) e - (f1) [In the formula, d is an integer of 1 to 200, and e is 0 or 1.] -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f2) [In the formula, c and d each independently represent an integer of 0 to 30; e and f are each independently an integer from 1 to 200; The sum of c, d, e and f is an integer from 10 to 200; The order of occurrence of each repeat unit enclosed in parentheses with the subscript c, d, e, or f is arbitrary in the formula. -(R 6 -R 7 ) g - (f3) [In the formula, R 6 is O.C.F. 2 Or O.C. 2 F 4 and R 7 , O.C. 2 F 4 , O.C. 3 F 6 , O.C. 4 F 8 , O.C. 5 F 10 and O.C. 6 F 12 or a combination of two or three groups selected from these groups; g is an integer from 2 to 100. -(R 6 -R 7 ) g -R r -(R 7’ -R 6’ ) g’ - (f4) [In the formula, R 6 is O.C.F. 2 Or O.C. 2 F 4 and R 7 , O.C. 2 F 4 , O.C. 3 F 6 , O.C. 4 F 8 , O.C. 5 F 10 and O.C. 6 F 12 or a combination of two or three groups independently selected from these groups; R 6’ is O.C.F. 2 Or O.C. 2 F 4 and R 7’ , O.C. 2 F 4 , O.C. 3 F 6 , O.C. 4 F 8 , O.C. 5 F 10 and O.C. 6 F 12 or a combination of two or three groups independently selected from these groups; g is an integer from 2 to 100; g' is an integer from 2 to 100, R r teeth, 【Chemistry 2】 (In the formula, * indicates the bond position.) is.]; -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f5) [In the formula, e is an integer of 1 or more and 200 or less, a, b, c, d, and f are each independently an integer of 0 or more and 200 or less, the sum of a, b, c, d, e, and f is at least 1, and the order of the repeating units enclosed in parentheses with a, b, c, d, e, or f is arbitrary in the formula.] -(OC 6 F 12 ) a -(OC 5 F 10 ) b -(OC 4 F 8 ) c -(OC 3 F 6 ) d -(OC 2 F 4 ) e -(OCF 2 ) f - (f6) [In the formula, f is an integer of 1 or more and 200 or less, a, b, c, d, and e are each independently an integer of 0 or more and 200 or less, the sum of a, b, c, d, e, and f is at least 1, and the order of the repeating units enclosed in parentheses with a, b, c, d, e, or f is arbitrary in the formula.] The curable composition according to claim 1 , wherein the group is represented by the formula:
6. X E The curable composition of claim 1 , wherein is a single bond.
7. X E is -X G -X H and X G teeth, Single bond, C 1-6 An alkylene group, - (CH 2 ) z9 -O-(CH 2 ) z10 - (wherein z9 is an integer from 0 to 6, and z10 is an integer from 0 to 6), or - (CH 2 ) z11 -phenylene-(CH 2 ) z12 (wherein z11 is an integer from 0 to 6, and z12 is an integer from 0 to 6). and X H is as follows: 【Chemistry 3】 and R 8 is a hydrogen atom or C 1-6 is an alkyl group, The curable composition of claim 1.
8. X D は、-O-、-CO-、-COO-、-OCO-、-CONH-、-NH CO-、-OCONH-、-NHCOO-、-NH-CO-NH-、-CH 2 CH(OH)CH 2 -、-CH(CH 2 OH)CH 2 -、-(OSiR 14 2 ) d5 -、 【Chemistry 4】 [In the formula, * and ** indicate bond positions, * indicates X B , and ** is X E binds to. and R 14 is C 1-6 Alkyl group, or C 6-16 is an aryl group, The curable composition according to claim 1, wherein d5 is an integer from 1 to 10.
9. X F teeth, Single bond, C 1-6 An alkylene group, - (CH 2 ) z5 -O-(CH 2 ) z6 - (wherein z5 is an integer from 0 to 6, and z6 is an integer from 0 to 6), or - (CH 2 ) z7 -phenylene-(CH 2 ) z8 (wherein z7 is an integer from 0 to 6, and z8 is an integer from 0 to 6).
2. The curable composition of claim 1, wherein
10. R 5 The curable composition according to claim 1 , wherein is a hydrogen atom or a methyl group.
11. X A each independently represents a single bond, or -(C α R 11 2α ) s1 -R 12 t1 - [In the formula: R 11 are each independently a hydrogen atom or a fluorine atom, Each a is independently an integer from 1 to 10, R 12 are each independently -O-, -CO-, or -NR 10 --CONR 10 --, --NR 10 CO-, -COO-, -OCO-, or -OCONH-; R 10 is a hydrogen atom or C 1-6 is an alkyl group, s1 is an integer from 0 to 3, t1 is an integer from 0 to 3, The sum of s1 and t1 is 1 or more, The order of occurrence of each repeating unit enclosed in parentheses with s1 or t1 is arbitrary in the formula. The curable composition according to claim 1 , wherein the group is represented by the formula:
12. X A is -CONR 10 -C α1 H 2α1 -, -(C α2 H 2α2 )-OCONR 10 -, -(C α3 H 2α3 )- or -(C α4 H 2α4 )-O-(C α5 H 2α5 ) and R 10 is a hydrogen atom or C 1-6 is an alkyl group, α1 is an integer from 1 to 10, α2 is an integer from 1 to 10, α3 is an integer from 1 to 10, α4 is an integer from 0 to 6, α5 is an integer from 0 to 6; The curable composition of claim 1.
13. X B are each independently SiR 1 nb R sb 4-nb [In the formula: R 1 is a hydroxyl group or a hydrolyzable group, R sb is a single bond, nb is 1 or 2. A group containing a group represented by the formula: The curable composition of claim 1.
14. X B are each independently Ba (R Si ) na [In the formula: X Ba are each independently a (m+na+1)-valent group, R Si are each independently -X C -SiR 1 n’ R 2 3-n’ and X C is a divalent organic group having 1 to 10 carbon atoms, R 1 are each independently a hydroxyl group or a hydrolyzable group, R 2 each independently represents a hydrogen atom or a monovalent organic group, n′ is an integer from 1 to 3, and na is an integer from 1 to 10. The curable composition according to claim 1 , wherein the group is represented by the formula:
15. X C teeth, C 1-6 An alkylene group, - (CH 2 ) z1 -O-(CH 2 ) z2 (wherein z1 is an integer from 0 to 6, and z2 is an integer from 0 to 6), - (CH 2 ) z3 -phenylene-(CH 2 ) z4 - (wherein z3 is an integer from 0 to 6, and z4 is an integer from 0 to 6), or -(CH 2 ) z13 -OCONH-(CH 2 ) z14 (wherein z13 is an integer from 0 to 6, and z14 is an integer from 0 to 6). The curable composition of claim 14, wherein
16. The curable composition of claim 14, wherein n' is 3.
17. X Ba The curable composition of claim 14 , wherein: is a trivalent group; n is 1; and m is 1.
18. X Ba The curable composition according to claim 14, wherein is N, or -C(-O-)-, n is 1, and m is 1.
19. Formula (A2) is 【Chemistry 5】 [In the formula, R b are each independently R Si , R Ac , or R c and However, R b At least one of Si and R Si are each independently -X C -SiR 1 n’ R 2 3-n’ and X C is a divalent organic group having 1 to 10 carbon atoms, R 1 are each independently a hydroxyl group or a hydrolyzable group, R 2 each independently represents a hydrogen atom or a monovalent organic group, n′ is an integer from 1 to 3, R d are each independently a single bond or a divalent organic group, R F2 , R a , R c , R Ac , m3, and x are defined as in claim 1.
2. The curable composition of claim 1, wherein
20. R bonded to the N atom located at each end in formula (A2) b One of them is R Si and the other is R c Or R Ac 20. The curable composition of claim 19, wherein
21. R d are each independently a single bond or -(CH 2 ) z17 -NR 10 - (CH 2 ) z18 - (wherein, R 10 is a hydrogen atom or C 1-6 20. The curable composition according to claim 19, wherein z17 is an alkyl group, z18 is an integer of 0 to 6, and z20 is an integer of 0 to 6.
22. R a are each independently represented by the following formula: -R 9 -(R a’ -R 9 ) k - [In the formula: R 9 are each independently 1-6 is an alkylene group, R a’ are each independently a trivalent group, k is an integer from 1 to 4. The curable composition according to claim 1 , wherein the group is represented by the formula:
23. R a’ each independently represents N, -C(-O-)-, or a trivalent group which may contain an amino bond, an amide bond, a urethane bond, a urea bond, an ether bond, or an ester bond between carbon atoms. The curable composition according to claim 22.
24. 23. The curable composition of claim 22, wherein k is 1 or 2.
25. R c are each independently a hydrogen atom or C 1-6 The curable composition of claim 1 , wherein the alkyl group is an alkyl group.
26. The curable composition according to claim 1 , wherein x is an integer of 1 to 5.
27. The curable composition according to claim 1 , wherein the fluoropolyether group-containing compound comprises a compound represented by formula (A1):
28. The curable composition according to claim 1 , wherein the fluoropolyether group-containing compound comprises a compound represented by formula (A2):
29. 2. The curable composition of claim 1, wherein the (meth)acrylic monomer is (a) a urethane (meth)acrylate, (b) an epoxy (meth)acrylate, (c) a polyester (meth)acrylate, (d) a polyether (meth)acrylate, (e) a silicone (meth)acrylate, or (f) a (meth)acrylate monomer.
30. The curable composition according to claim 1, wherein the radical polymerization initiator is a diketone, an acyloin, an acyloin ether, a thioxanthone, a benzophenone, an acetophenone, a quinone, an aminobenzoic acid, a halogen compound, an acylphosphine oxide, or a peroxide.
31. The radical polymerization initiator may be benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, thioxanthone, 2,4-diethylthioxanthone, thioxanthone-4-sulfonic acid, benzophenone, 4,4'-bis(dimethylamino)benzophenone, 4,4'-bis(diethylamino)benzophenone, acetophenone, 2-(4-toluenesulfonyloxy)-2-phenylacetophenone, p-dimethylaminoacetophenone, 2,2'-dimethoxy-2-phenylacetophenone, p-Methoxyacetophenone, 2-methyl[4-(methylthio)phenyl]-2-morpholino-1-propanone, 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butan-1-one, anthraquinone, 1,4-naphthoquinone, ethyl 2-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate, (n-butoxy)ethyl 4-dimethylaminobenzoate, isoamyl 4-dimethylaminobenzoate, 2-ethylhexyl 4-dimethylaminobenzoate, phenacyl chloride, trihalomethylphenyl sulfone , acylphosphine oxide, or di-t-butyl peroxide, methyl benzoyl formate, 1-hydroxy-cyclohexyl-phenyl-ketone, 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propan-1-one, 2-hydroxy-1-{4-[4-(2-hydroxy-2-methyl-propionyl)-benzyl]phenyl}-2-methyl-propan-1-one, 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one, 2-benzyl-2-dimethyl dimethylamino-1-(4-morpholinophenyl)-1-butanone, 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(4-morpholinyl)phenyl]-1-butanone, bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide, bis(η5-2,4-cyclopentadiene-1-yl)-bis(2,6-difluoro-3-(1H-pyrrol-1-yl)-phenyl)titanium, 1,2-octanedione, 1-[4-(phenylthio)-, 2-(O-benzoyloxime)], ethanone,The curable composition according to claim 1, which is 1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]-, 1-(0-acetyloxime), 2-hydroxy-2-methyl-1-phenyl-propan-1-one, 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide, t-butyl hydroperoxide, cumene hydroperoxide, diisopropylbenzene hydroperoxide, permentha hydroperoxide, or t-methylbutyl hydroperoxide.
32. The curable composition of claim 1 further comprising a solvent.
33. A cured product obtained from the curable composition according to any one of claims 1 to 32.
34. An article comprising a substrate and a layer formed on a surface of the substrate from the curable composition according to any one of claims 1 to 32.
Citation Information
Patent Citations
Primer composition
JP2004331704A
Reactive fluorine-containing oligomer
JP2014070113A
Fluorine-containing, silicon-containing polymer and surface treatment agent
JP2014224235A
Fluoropolyether group-containing compound
JP2020164847A
Surface preparation agent
JP2020196867A
